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Abstract 
Many physicians report minimal clinical genetics education and feel ill-prepared to discuss 
genetic information with their patients.1,2 This study assessed the clinical genetics knowledge of 
University of Pittsburgh medical students through an online survey. The students were asked to 
rate their confidence in their knowledge of clinical genetics concepts and then answer multiple-
choice questions that elicited knowledge concerning inheritance, clinical scenarios, and genetic 
test selection. The survey was distributed three months after the students took a 21-day Human 
Genetics course, required for all first year medical students at the University of Pittsburgh.  
Out of 147 medical students, 10 completed the survey (a response rate of 6.8%). Medical 
students’ responses suggested they are confident in their understanding of foundational genetic 
concepts such as the central dogma and inheritance but are less confident in collecting family 
histories and identifying indications for genetics referral. Contrary to the respondents’ confidence 
levels, the knowledge assessment revealed that students often incorrectly answered knowledge 
questions pertaining to inheritance and appropriate test selection. Students had lower confidence 
scores and lower knowledge scores for clinical genetics resources, testing strategy, and test 
interpretation. Most students reported experience with molecular genetics through undergraduate 
coursework; a minority reported genetics-related clinical or research experience. There was no 
significant difference between respondents who reported prior genetics clinical or research 
v 
experience and those who did not, suggesting that all medical students would benefit from learning 
the breadth of both molecular and clinical genetics in medical school curriculum. 
These results signify a need for genetics education that is pertinent to advancements in 
clinical genetics. This study is significant to public health because physicians with limited 
formal genetics education are at increased risk of accidentally ordering the wrong genetic test, 
failing to refer a patient in need of genetic services, or unintentionally providing misinformation 
during results disclosure, which can jeopardize the quality of care for patients and limit equitable 
access to healthcare.3-6 To build a skilled public health workforce, medical students must possess 
basic knowledge of clinical genetics concepts and resources to make appropriate decisions 
regarding genetic information in the clinical setting as future physicians.  
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1.1 Background and Specific Aims 
Recent advances in genetic testing have provided a wealth of genetic information not 
accessible in years past. To provide diagnostic information for patients with suspected genetic 
conditions, genetic testing in clinical settings is becoming more commonplace, with the outcomes 
of those test results impacting patient care and extending beyond the patient to their family. In 
addition to clinical genetic testing, consumers have access to personal genomic, or direct-to-
consumer (DTC) testing services, which provide personal health and ancestry information, though 
the utility of this information is debatable.7 Genetics is more accessible than ever before, yet a 
large portion of the population demonstrates limited genetic literacy, presenting challenges for 
health care providers in communicating genetic information, which is often complex.8 The future 
of medicine is intertwined with advances in genetics, presenting ethical dilemmas concerning 
informed consent and the privacy of genetic information. To prepare for this future, health care 
providers must learn to incorporate genetic concepts, such as inheritance patterns, family history, 
and awareness of genetic conditions into their practice alongside full disclosure of the ethical 
concerns related to genetic testing.  
Despite this reality, health care providers, particularly physicians, report little formal 
genetics education and feel ill-prepared to discuss genetic information with their patients.2 Studies 
have shown that providers without formal genetics education are at increased risk of accidentally 
ordering the wrong genetic test, failing to refer a patient in need of genetic services, or 
unintentionally providing misinformation.3,9,10 While most studies to date have surveyed 
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physicians directly, there is little information regarding the genetic literacy of medical students at 
the beginning of their training as compared to when they graduate. Additionally, most tools used 
to assess genetic literacy assume a limited familiarity with genetics terminology. Since medical 
students are a health literate population and are presumably familiar with words like “gene” and 
“chromosome”, genetics knowledge can be used as a proxy for genetic literacy 
To assess the genetic knowledge of soon-to-be physicians, a survey was administered to 
147 first-year University of Pittsburgh medical students. The survey was designed to assess 
knowledge of clinical genetics and genetic testing, as well as self-confidence in those genetic 
concepts, in relation to their Human Genetics course, a 21-day course that is required for all first-
year medical students at the University of Pittsburgh. The information gained from this study has 
the potential to influence the content of medical student’s genetic education by identifying areas 
in which student’s knowledge is lacking.  
While this study addresses the first iteration of the survey, distributed three months 
following the conclusion of the Fall 2020 course with the goal of getting preliminary data on 
content retention, future studies will aim to track medical students’ improvements in knowledge 
over time during their training. Detailed information concerning knowledge gaps will inform 
future efforts to further integrate and expand genetics in medical school curriculum. 
1.1.1 Specific Aim I 
To develop a survey to assess the University of Pittsburgh medical students’ genetic 
literacy and clinical genetics knowledge as well as their familiarity with clinical genetics concepts. 
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1.1.2 Specific Aim II 
To evaluate the process by which medical students acquire genetic knowledge during their 
training.  
 4 
2.0 LITERATURE REVIEW 
2.1 Defining Genetic Literacy 
Genetic literacy, a subset of health literacy, is defined as “sufficient knowledge and 
appreciation of genetics principles to allow informed decision-making for personal well-being and 
effective participation in social decisions on genetic issues”.11 According to Joseph McInerney, 
former executive vice president of the American Society of Human Genetics, genetic literacy is 
vital to “understanding the history and nature of life on earth, as well as understanding the future 
of health care, including the ethical, legal, and social aspects of health care and the genetic 
contributions to health care”.12  
Though a number of Americans have some familiarity with genetics through its coverage 
in media, this awareness of genetics does not constitute being genetically literate. A minority of 
Americans are considered to have a sufficient degree of genetic literacy necessary to make medical 
management decisions based on genetic information. In essence, many American citizens are 
conversationally familiar with genetics but lack the fundamental scientific framework to 
contextualize genetic information and this can result in an unintentional overestimation of 
understanding.13   
Despite the lack of genetic literacy in the general population, genetics has a growing impact 
on healthcare, serving as a major checkpoint in the diagnostic odyssey for many with acute and 
chronic health conditions. A considerable proportion of the population is affected by a genetic 
disorder. Around 1 in 50 people have a single-gene disorder, while 1 in 263 have a chromosomal 
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condition.14 Even genetic conditions that are defined as “rare” are relatively common; when rare 
disorders are considered collectively, 1 in 21 people in the general population are affected.14. 
While there is still much to be discovered about the role of genes in health and disease, 
genetic testing in clinical settings is becoming more commonplace, with the outcomes of those test 
results impacting patient care and extending beyond the patient to their family. As advances in 
healthcare progress towards precision medicine, there is a need for genetics education for both the 
public and healthcare providers. Bridging the patient-provider literacy gap can allow for more in-
depth discussions of genetic risk and provide the opportunity for appropriate informed consent.  
2.2 Genetic Literacy in the General Population 
Demographic factors such as older age, limited education, lower income, and status as a 
non-native English speaker are known to be associated with low health literacy and may also be 
associated with low genetic literacy.8,15,16 Other individual risk factors include limited 
understanding of biology and poor numeracy (particularly concerning probability, statistics, and 
risk), which may not be immediately obvious to the provider during the first encounter with a 
patient.  
Individuals with low genetic literacy have a tendency to use “gene”, “chromosome”, and 
“DNA” interchangeably without knowing the biological nuance of such terminology.17 Similarly, 
patients may not recognize that all humans share the same number of genes; it is variation within 
the genes that influences an individual’s risk for disease. This misconception can be identified by 
a patient stating that they have the “gene” for a condition, rather than a genetic change within the 
gene. Another common misconception is the erroneous assumption that genetic factors alone 
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influence risk for common multifactorial conditions, rather than the complex interplay of genetic 
factors and environment. Patients may, for instance, believe that there is a “gene” that causes 
diabetes, a known multifactorial condition, given that the condition exists in several family 
members. Other common fallacies include the environment consisting solely of influences from 
the natural world instead of including an individual’s lifestyle choices, as well as the idea that 
genes exist solely in the brain or gonads rather than distributed throughout most cell lines in the 
body.13 
A common misconception about genetic literacy is that individuals with average or high 
health literacy also possess high genetic literacy. In one study of health literate individuals at high 
risk to develop type 2 diabetes, 30% of participants had limited health numeracy and 38% had 
limited genetic literacy.18 Similarly, an international study using the International Genetic Literacy 
and Attitudes Survey (iGLAS) found that genetics knowledge was generally poor (average 
genetics knowledge test score = 65.5%) regardless of demographic factors i.e. country of origin, 
profession, education level and religious affiliation.19 While there is a positive correlation between 
education and genetics knowledge, even college-educated individuals are not always genetically 
literate, leading to concerns about the degree of genetic literacy achieved in both undergraduate 
and graduate education. One cohort of college undergraduate students pursuing degrees outside of 
the biological sciences scored only 45% on average using the Genetic Literacy Assessment 
Instrument.11 
2.2.1 Tools to Assess Genetic Literacy 
In evaluating a patient’s degree of genetic literacy, one approach is to consider E.M. 
Rogers’ hierarchy of knowledge, which describes the diffusion of a novel concept such as genetics 
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into the everyday life of an average person. Rogers’ framework maintains that basic familiarity 
with genetic terminology is obtained first, followed by being able to contextualize basic genetic 
information for informal personal application; the highest order of the framework is understanding 
the underlying biological principles and mechanisms of genetics.20 Consider an example of a 
patient reading a genetic test report that reveals a BRCA1 pathogenic variant. The patient may be 
somewhat familiar with the term “gene” or “DNA” (the “what”). If they have achieved the next 
order of knowledge, the patient may be able to comprehend the notion that this mutation will 
increase their lifetime risk for certain cancers and alter their medical management, as well as 
understand that certain other relatives are at risk to have inherited this mutation (“how-to”). Few 
patients will understand the mechanisms of disease at the molecular level, in this case the BRCA1 
protein’s role in transcription and double strand break repair (“why”).21   
The Rapid Estimate of Adult Literacy in Genetics (REAL-G) assessment addresses the 
“what” of Rogers’ hierarchy.21 REAL-G was created in 2007 to aurally screen for low genetic 
literacy in patient populations in clinical or research settings by asking subjects to read standard 
genetic terminology aloud to assess fluency.22 Similarly, the Genetic Literacy and Comprehension 
measure (GLAC) evaluates genetic literacy by asking participants to rank familiarity with 8 
commonly used genetic words and concepts: Genetic, Chromosome, Susceptibility, Mutation, 
Variation, Abnormality, Heredity, and Sporadic using a 7-point scale (strongly agree to strongly 
disagree with the statement “I am familiar with this term”).  
REAL-G and GLAC have both been utilized in research that addresses the first portion of 
Rogers’ hierarchy in regards to genetic literacy, but are more applicable to the general population 
when compared to individuals immersed in health and scientific pursuits.22,23 In other words, these 
instruments address literacy rather than genetics knowledge and evaluation of content in 
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educational settings. As one author argues, evaluating an individual’s genetic literacy, particularly 
in the context of highly educated individuals, should more heavily emphasize the practical skills 
and factual knowledge portions, as these are more salient to the interpretation and clinical 
application of risk information.21 Practical skills and factual knowledge can be assessed using 
scenario-centered questions and multiple choice or true/false statements, respectively.  
In the academic setting, the Genetics Literacy Assessment Instrument (GLAI) has been 
used to evaluate genetics education at both the undergraduate and medical school level. The GLAI 
was developed to evaluate the factual knowledge component of genetic literacy in undergraduate 
students taking introductory biology courses.11 This survey is a 31-item multiple-choice test that 
addresses 17 concepts identified as central to genetics literacy, including the ASHG-mandated six 
concept areas for genetic literacy for non-science majors at the undergraduate level (described in 
further detail below). The GLAI was created to evaluate genetic literacy as relevant to everyday 
life at the undergraduate level, particularly for non-biology majors, but the authors suggest that the 
survey may be helpful in assessing the genetic literacy of other populations.  
To evaluate genetic literacy internationally, the International Genetic Literacy and 
Attitudes Survey (iGLAS) was developed by a collaborative team from Goldsmiths, University of 
London, Tomsk State University, and The Accessible Genetics Consortium (TAGC). iGLAS has 
four sections: knowledge, attitudes, a personality measure, and demographics. The demographics 
section includes sex, education level, employment, parental status (number of children), country 
of secondary education, country of residence, religious affiliation, religiosity level, spirituality 
level, and political ideology. The anonymous online survey was developed in English and Russian 
and has been administered to thousands of participants. Translations are currently available in 
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Spanish, French, Italian, Romanian and Albanian. The latest version of the study can be found at 
http://tagc.world/iglas/. 
While previously mentioned studies have assessed genetics knowledge alone, other studies 
have attempted to find correlations between genetics knowledge and attitudes towards genetics. A 
recent study examined the knowledge and attitudes towards medical genetics in students of the 
Medical Faculty in Rijeka, Croatia. Students at this institution are required to take a medical 
genetics course during their 5th year; the impact of this course was evaluated based on the change 
in knowledge, attitudes, and personal assessment of knowledge in medical genetics, all of which 
were found to have improved after taking the genetics course.24 Positive attitudes were correlated 
with higher levels of knowledge, implying that exposure to needs-based theoretical and practical 
education results in a strong foundation in genetics knowledge, which improves student’s self-
confidence in providing genetics services in a clinical setting. The student’s self-confidence was 
reflected in their greater willingness to work directly with patients, a positive view of their own 
education, and the ability to clearly convey information about genetic conditions while respecting 
the patient’s autonomy. 
2.3 Outcomes of Limited Genetic Literacy in Patient-Provider Interactions  
Assessing a patient’s genetic literacy level when preparing to have a conversation about 
genetics can be a challenge for healthcare providers. Experienced and genetically literate health 
care providers may be able to identify specific signs of low genetic literacy, which in some cases 
may also be signs of low health literacy. Regardless, these misunderstandings have the potential 
to complicate diagnosis and treatment as well as diminish patient satisfaction, as patients with low 
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genetic literacy are more likely to have poor information recall following a genetics-oriented 
conversation with a health care provider.16,25 This puts the patient at increased risk for potentially 
problematic misconceptions of the natural history, surveillance, and treatment of their genetic 
condition, and may lead to over- or underestimations of the risk to other family members.26,27 
Consequently, individuals may hold harmful misconceptions about genetics and genetic testing. 
They may be unaware of trustworthy scientific resources to educate themselves, making them 
vulnerable to false or inaccurate information encountered online or in daily life. Patients who lack 
the biological framework for understanding a genetic diagnosis are more likely to experience 
confusion and frustration, confounding their care and contributing to feelings of depression and 
isolation.8 Though assumption of a patient’s genetic literacy level may be a sensitive topic, it is 
crucial for providers to recognize characteristics of a patient that may indicate low genetic literacy 
and to err on the side of caution when explaining genetic terminology and its relevance to the 
patient’s health.  
There are methods by which health-care providers can counter health and genetic illiteracy. 
Simplifying patient reading materials (i.e., patient letters, test reports, and pamphlets) can increase 
patient recall by providing a legible resource to reference at a later date and to share with relatives 
who may have varying degrees of health and genetic literacy. Strategies for more effective written 
communication include defining genetic terminology, replacing medical jargon with common 
language, and including images to illustrate difficult to understand concepts. Perhaps the most 
common verbal technique for reinforcing a difficult to grasp concept is the “teach-back” method 
of asking the patient to share her/his understanding of the information. Ultimately, by providing 
clear definitions and context for a patient’s unique situation, healthcare providers can enable the 
opportunity for understanding and informed consent for the patient and family members. 
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2.4 Genetic Literacy and Clinical Genetics Knowledge in Physicians 
In 2017, there were approximately 75,000 genetic tests on the market, with the majority 
being prenatal genetic tests and hereditary cancer genetic tests.1,28,29 As the number of patients who 
undergo genetic testing increases, so too does the need for not only genetic counselors, geneticists, 
and other genetics clinicians, but also for genetically literate healthcare providers outside of 
clinical genetics. Given that many non-genetics affiliated healthcare providers (HCPs) are likely 
to encounter patients in need of genetic counseling, it is important to consider what education 
HCPs receive concerning genetics and genetic testing, as well as who is involved with the 
provision of genetic services in healthcare. There is a distinct connection between a provider’s 
genetic literacy and their clinical genetics knowledge; measuring a provider’s clinical genetics 
knowledge serves as a proxy for genetic literacy in an already health literate, highly educated 
population. 
Unfortunately, many HCPs, particularly physicians, report little formal genetics education 
and feel ill-prepared to discuss genetic information with their patients.2 Through analysis of three 
types of knowledge related to genetic literacy (awareness, “how-to”, and principles), one 
systematic review of twenty-one studies found that genetic literacy in oncologists is limited across 
all three knowledge types, only one such example of a significant trend revealing a lack of genetics 
education in non-genetics affiliated physicians.30 One survey of internists reported that 65% had 
counseled patients on genetic issues, but more than 70% of the internists described their personal 
knowledge of genetics as “very/somewhat poor”, particularly in the context of counseling patients, 
selecting an appropriate test, and knowing the guidelines for a genetics referral.1 Conversely, a 
different study found that despite confusion surrounding interpretation of variants of uncertain 
significance (VUS) and management of patient emotions, up to 61% of non-genetics healthcare 
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providers had a positive attitude towards their knowledge of genetic testing options for hereditary 
cancer with almost half of respondents ordering more than 30 of these tests per year.3 
2.4.1 Clinical Genetics Knowledge in Primary Care Physicians 
A significant amount of research has examined the genetic literacy of primary care 
providers’ given their role as a patient’s first point of contact for health care. Despite the critical 
services primary care physicians (PCPs) provide, deficiencies in several key skills essential to 
provision of genetic services have been identified, most notably ethical, legal, and social 
implication (ELSI) issues related to screening for genetic conditions, and basic knowledge of 
clinical genetics.31,32 There is a need for the expansion of PCP’s understanding of fundamental 
genetic principles, genetic test characteristics, and professional guidelines regarding testing, as 
well as promoting effective patient communication strategies about genetic risk and testing, 
specifically with regards to hereditary cancer genetic testing.31 Patients should always take part in 
a thorough discussion for informed consent before electing to proceed with a genetic test. This 
discussion may include ELSI issues such as the clinical and personal utility of information 
garnered from a genetic test, the impact on medical management, federal protections related to 
genetic discrimination, the distinction between testing for clinical care and testing for research 
purposes, the possibility of secondary or incidental findings, among others.33 Partnerships with 
genetic professionals can pave the way for improving access to genetics education of healthcare 
providers. 
Commonly cited barriers to integration of genetics services in primary care include a lack 
of knowledge about genetics and genetic risk assessment, concern for patient anxiety, and a lack 
of time both to counsel patients and to learn about genetic concepts.34 Fortunately, this problem 
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may be rectified through the provision of continuing education experiences by academic 
institutions, medical institutions, and professional societies. Providers can be incentivized to 
pursue these opportunities through continuing education credits and other paid trainings. Both 
web-based modules and traditional continuing education experiences are effective in educating 
PCPs. Some evidence suggests that web-based content results in improved knowledge retention 
and preference for shared decision making, a two-way communication model where the provider 
and patient develop a partnership to make a decision based on empathy and respect for the patient’s 
belief system and level of genetic literacy.35,36  
Since PCPs have established relationships within the community and well-defined roles as 
providers of preventative medicine and health education, they are ideal candidates for genomics 
education efforts. In addition to promoting open and effective patient-provider communication 
about genetic risk and genetic testing, addressing the educational needs and role of genetics in 
primary care may improve genetics risk assessment, increase genetics specialist referral rates, and 
provide a platform for the integration of precision medicine.31,37-39 Genomics education moving 
forward should take a multi-pronged approach through forging partnerships between PCPs and 
genetics professionals, providing educational genetics experiences in the context of the field of 
primary care, and pursuing further research to tailor these educational strategies.37 
2.4.2 Clinical Genetics Knowledge in Pediatricians 
Early identification of a genetic condition in a child is crucial for promoting growth and 
development. In many cases, the first sign of a genetic condition in a child is Global developmental 
delay (GDD), which affects 1% to 3% of children.40 Unfortunately, genetic testing is underutilized 
in pediatrics due to a lack of information surrounding testing guidelines. One survey from 2018 
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identified that 68% of pediatricians were not familiar with any genetic testing guidelines for a 
patient with global developmental delay (GDD).  Although a majority of the 225 participants had 
ordered genetic testing for children with GDD, the study found that almost all providers would 
order genetic testing if a child presented with dysmorphic features and GDD, but only a minority 
(20.6%) would order testing for a case of isolated GDD.41 This is contrary to the American Society 
of Human Genetics and the American College of Medical Genetics and Genomics (ACMG) 
position statements recommending chromosomal microarray as a first-tier clinical diagnostic test 
for individuals with apparent non-syndromic developmental disabilities and GDD.42,43 
2.4.3 Clinical Genetics Knowledge in OB/GYNs 
Uncertainty has long been a factor of prenatal genetic counseling, though the vast wealth 
of information accessible through new prenatal genetic technologies deepens that uncertainty 
further than ever before.44 For instance, the rise of cell-free DNA (cfDNA) screening from a 
maternal blood sample has resulted in an increased ability to detect common aneuploidies and even 
certain microdeletion syndromes as early as 10 weeks gestation.45 In addition, the American 
College of Obstetrics and Gynecology (ACOG) has recommended that prenatal chromosomal 
microarray analysis is the standard of care offered to patients with a fetus with one or more major 
structural abnormalities identified on ultrasonographic examination and who is undergoing 
invasive prenatal diagnosis (chorionic villus sampling or amniocentesis).46 The use of advanced 
genetic diagnostic tools in the event of a suspected fetal anomaly may provide answers for 
expecting parents, but understandably may cause distress. Carrier screening, whether ethnic-based 
or expanded, can provide couples with risks for certain autosomal recessive conditions prior to 
conceiving. 
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While more than 90% of OB/GYNs offer ethnic-based carrier screening, many OB/GYNs 
do not routinely offer expanded carrier screening (ECS) to their patients.47 Contrary to the 
American College of Obstetricians and Gynecologist’s statement that expanded carrier screening 
should be offered as part of preconception and pregnancy care, one survey of OB/GYNs from 2016 
found that only 27% of practicing OB/GYNs offer expanded carrier screening to their patients, 
though notably, reproductive endocrinology/infertility and maternal fetal medicine specialists 
were significantly more likely to offer expanded carrier screening (80 and 70% offer ECS, 
respectively).47,48 Similarly, another survey of OB/GYNs found that while all were familiar with 
cfDNA screening, or noninvasive prenatal testing (NIPT) the vast majority of these respondents 
(91%) felt that they needed more education on NIPT before offering the expanded version of NIPT 
to their patients.49 One place to start expanding genetic testing education would of course be 
residency, however as of 2019 only 14.3% of OB/GYN residency programs have incorporated a 
medical genetics and genomics rotation; these rotations were generally shorter compared to other 
rotations such as family planning or ultrasound.50 
Evidence suggests that the genetic literacy of pregnant women, as assessed by the Genetic 
literacy and Comprehension Measure (GLAC), does not impact their use of prenatal screening or 
diagnostic tests.51 However, a patient with limited genetic literacy may struggle to communicate 
with and understand recommendations from their healthcare provider. As a result, patients may 
experience frustration or confusion, or worse, may make inappropriate management decisions 
based on miscommunication of genetic test results.52 Therefore, healthcare providers involved with 
prenatal screening and diagnosis of genetic disorders should be prepared to counsel women of 
varying levels of genetic literacy and provide appropriate pre- and post-test counseling. 
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2.4.4 Clinical Genetics Knowledge in Oncologists 
Hereditary cancer predisposition syndromes are caused by pathogenic germline variants, 
most often in tumor suppressor genes. Early identification of a cancer predisposition syndrome 
can significantly impact medical care by providing therapeutic options, syndrome-specific 
surveillance, and prevention guidelines alongside disease management recommendations. 
Moreover, identifying a cancer predisposition may provide a long-sought explanation for the 
“family disease” and therefore initiate cascade testing for relatives of the affected individual. To 
discern between hereditary, familial, and sporadic forms of cancer, providers must utilize thorough 
risk assessment alongside knowledge of current genetic testing guidelines. Oncologists and other 
specialists who are providing care to patients with a personal and/or family history of cancer should 
have a working knowledge of hereditary forms of cancer. Patients with hereditary breast/ovarian 
and hereditary non-polyposis colorectal cancer (HNPCC) syndromes, while uncommon in the 
general population, can present in standard oncology practices.  
Despite this reality, numerous studies demonstrate limited knowledge of genes associated 
with hereditary cancers in many non-genetics healthcare providers, including but to a lesser degree 
oncologists.5,6,53 Many providers are familiar with BRCA1/2 but are unaware of other genes 
associated with hereditary forms of breast cancer, which often necessitates the need for multigene 
panel testing rather than BRCA1/2 alone. In accordance with NCCN guidelines, multigene panel 
testing for both high- and moderate- risk breast cancer genes are indicated in many patients.54 Still, 
there are instances where oncologists have failed to test even for BRCA1/2 mutations in a patient 
with a family history suggestive of hereditary breast and ovarian cancer (HBOC), resulting in 
missed opportunities for preventative treatment, surveillance of at-risk relatives, and therapeutic 
opportunities such as the use of PARP inhibitors and other targeted therapies.2,10,55-57 Conversely, 
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one study found that in families with known pathogenic variants, where single-site testing of 
BRCA1/2 would be appropriate, fewer than 35% of physicians correctly ordered single-site testing 
and instead ordered panel testing, resulting in excess medical costs to the patient.58 This study did 
reveal that oncologists were the most likely specialty to correctly select single-site testing (38% of 
oncologists surveyed), but a significant portion opted for more expensive measures including 
BRCA1 sequencing or comprehensive BRCA analysis.  
BRCA1/2 testing has existed since the late 1990’s, but studies conducted within the last 
decade have shown that genetic counseling referral rates for women with epithelial ovarian cancer 
can vary between medical centers. While some hospitals report referral rates for women high-
grade serous ovarian cancer as high as 95%, other institutional referral rates are as low as 
31%.55,59,60 One 2015 study found that only 31% of 104 epithelial ovarian cancer patients received 
a referral for genetic counseling from their oncologist. Similarly, genetic counseling referral rates 
from oncologists for male breast cancer, a rare cancer also correlated with pathogenic variants in 
BRCA1/2, are low, highlighting the need for provider education about cancer risks in males 
associated with hereditary predisposition syndromes.61 
Other hereditary cancer etiologies are known to manifest with extra-oncological findings 
that could be identified through consultation with a genetic counselor. For instance, individuals 
with PTEN hamartoma tumor syndrome may present with learning disabilities, acral keratoses, 
and macrocephaly in addition to an increased incidence of breast, endometrial, and thyroid cancers, 
among others. Instances of physicians missing this potential diagnosis on the basis of not taking a 
detailed family history and/or lack of familiarity with the condition have been reported.62 The 
National Comprehensive Cancer Network (NCCN) offers evidence-based risk assessment and 
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referral guidelines for these and many other hereditary cancer syndromes. Oncologists can utilize 
these and other resources to make a referral to cancer genetics when appropriate. 
2.5 Consequences of Limited Genetic Literacy in Physicians 
In recent years, non-genetics healthcare providers, most commonly oncologists and 
obstetricians/gynecologists, have ordered significantly more genetic tests as part of their 
practice.1,28 Evidence suggests that up to one-third of these tests were inappropriately ordered, 
either because they did not comply with practice guidelines, provided false reassurance to the 
patient, or failed to cover all involved differential diagnoses.63  
Physicians with limited formal genetics education are at increased risk of accidentally 
ordering the wrong genetic test, failing to refer a patient in need of genetic services, or 
unintentionally providing misinformation during results disclosure.3-6 These mistakes could result 
in harm to the patient and point toward the need for more physician training in selecting the 
appropriate genetic test, recognizing when referral to genetic services is necessary, as well as for 
utilization management through review of tests orders by a certified genetic counselor or genetics 
specialists. 
Research has identified that medical management decisions have been based upon the 
misunderstanding of a variant of uncertain significance (VUS) as causative of disease including 
the recommendation that family members be tested for an identified variant of uncertain 
significance.5,6,53 The American College of Medical Genetics states that testing for these variants 
is unnecessary because by their very definition, they do not impact patient care.64 However, 
evidence suggests that non-genetics healthcare providers would recommend or have recommended 
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that family members be tested for a VUS.5,6,53 Education on genetic testing including the 
interpretation of results would conceivably reverse this trend.  
2.6 Workforce Data on Genetics Specialists  
Workforce data on medical genetics specialists have revealed a stark contrast between the 
increasing demand for genetic testing and the number of available genetics providers, particularly 
geneticists. One survey of medical genetics providers revealed that 25% of geneticists reported 
that they expect to retire in the next 5 years.65 Given the aging workforce, genetics residency 
programs are attempting to recruit more applicants, but their efforts have yielded little success. In 
fact, genetics residency programs are currently reporting a lack of applicants; over the past several 
years many programs have not had enough applicants to fill all spots within the program.66 The 
shortage of both current and aspiring medical geneticists points to an impending magnification of 
the current situation, which is already critical. For instance, wait times for combined genetic 
counselor and geneticist appointments, an arrangement necessary for many pediatric and adult 
indications, frequently exceed 4 months.67,68 While the genetic counseling profession is rapidly 
expanding and genetic counselors are utilizing their scope of practice in new roles, the demand for 
genetic counseling still far exceeds the supply. A recent study on the genetic counseling workforce 
indicated a shortage of genetic counselors engaged in direct patient care, with the supply and 
demand not expected to reach equilibrium until sometime between 2024 and 2030.67 
Different service delivery and practice models have been proposed to ameliorate the 
genetic specialist shortage. For example, efforts have focused on providing medical genetics 
training to mid-level providers (such as nurse practitioners and physician assistants) who are 
 20 
licensed to perform physical examinations. Roles for physician assistants (PAs) and nurse 
practitioners (NPs) within clinical genetics have existed for decades but are often secondary to 
their official job duties within a broader department, for instance, oncology or maternal fetal 
medicine. The expansion of full-time genetics specialization would introduce more PAs and NPs 
to the profession. In addition, there has long been a need in the genetic counseling profession for 
increased autonomy independent of physicians, which can be achieved through federal policies 
such as expansion of licensure and recognition of genetic counselors as healthcare providers by 
Medicare and Medicaid services, which would allow them to be reimbursed under Medicare.38  
Meanwhile, in order to keep all genetics professionals working “at the top of their scope”, hiring 
additional support staff (i.e. genetic counseling assistants) can serve to improve workplace 
efficiency, as well as provide a pathway for aspiring genetics professionals to enter the field.38,68 
2.7 Access to Genetic services 
To better prepare for a future where genetics is expected to play a greater role in clinical 
care, non-genetics healthcare professionals will need to incorporate genetic concepts, such as 
inheritance patterns, family history, and basic awareness of genetic conditions into their practice. 
Yet integration of genetics services has been slow to progress.  
Non-genetics healthcare providers should not be expected to fulfill the same roles as 
genetics specialists. Individualized practice-based competencies (PBCs) are established for 
various professions with a role in providing care to individuals with genetic conditions. Currently, 
PBCs are easily accessible through the Genetics and Genomics Competency Center (G2C2) for 
physicians, genetic counselors, pharmacists, physician assistants, and nurses. In the case of genetic 
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counselors and nurses, PBCs were crafted through their respective accrediting body (Accreditation 
Counsel for Genetic Counseling; American Nurses Association) while those for physician 
assistants and pharmacists were created through a conglomerate of several professional 
organizations.69-71 At the most basic level, providers should be able to identify patients in need of 
genetic services through basic knowledge of the characteristics of genetic conditions and 
inheritance patterns. Health care institutions could foster connections between primary care 
doctors and genetics teams to create open lines of communication for questions and continuity of 
patient care. Finally, if a provider chooses to refer a patient to genetics, the provider should explain 
to the patient why they are being referred and how genetics could impact the course of care. 
2.7.1 Barriers to Genetic Counseling Services 
Numerous factors have been cited for the lethargic integration of genetics into health care, 
including access to and knowledge of genetic counseling. As with generalized medical care, but 
perhaps to a greater degree, physical and financial barriers continue to impede patient access to 
genetic counseling services despite expansion of different care delivery models.38,72 As of 2020, 
genetic counselors are still concentrated in large, urban medical centers. Patients living in rural 
areas may have to travel a considerable distance to meet with a genetic specialist, despite efforts 
to expand care through rural outreach programs and telemedicine. Some patients continue to have 
inadequate access to technology for telemedicine. Scheduling conflicts, out-of-pocket costs, and 
long wait times continue to be barriers, especially for lower-income patients. In low-income 
populations, health and genetic literacy is often lower. It is not uncommon for individuals with 
limited health or genetic literacy to present for a genetic counseling appointment with little to no 
understanding as to why they were referred to genetics. When so many seemingly insurmountable 
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barriers exist, from the patient’s perspective the benefit of attending a genetic counseling 
appointment can appear low, especially if the patient does not understand how genetics impacts 
their course of care.73  
Patients often cite emotional or familial reasons for deferring genetic testing and not 
seeking genetic counseling services.72  Some patients prefer to direct questions about genetic 
testing towards their general practitioner prior to or instead of seeking the services of a genetic 
professional with whom they do not have a professional relationship.74  This may be related to the 
limited public familiarity with the genetic counseling profession, though recent efforts to increase 
public awareness of the field, a nationwide growth in the number of genetic counselors and greater 
public familiarity with genetic conditions, may change this perception in time. However, as 
described in the previous section, there remains a nationwide shortage of geneticists that continues 
to hamper access to genetic services for patients in need of a physical examination, which genetic 
counselors are not licensed to perform, and coordination of care with other specialists.  
2.8 The Current Status of Genetics Education  
2.8.1 Recommendations and Guidelines for Undergraduate Education 
Research has assessed the impact of undergraduate education in understanding genetic 
information. In a 2002 survey of undergraduate biology course instructors, the respondents 
expressed that they felt undergraduate students lack both depth in understanding of genetic 
concepts and the ability to relate genetics to everyday life. In response, the education committee 
of the American Society of Human Genetics (ASHG) developed a set of six concept areas for 
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genetic literacy for non-science majors at the undergraduate level consisting of the Nature of the 
Genetic Material, Inheritance and transmission, Gene Expression, Gene Regulation,  Evolution, 
and Genetics and Society.12,75 Other researchers have criticized these domains as emphasizing 
Mendelian genetics too heavily, less focus on important concepts related to multifactorial 
inheritance, variable expressivity and penetrance, polygenic traits, and other aspects of complex 
genetic disorders.76  
2.8.2 Recommendations and Guidelines for Medical School Curriculum 
To acknowledge and confront the widening gap between clinical incorporation of genetics 
into educational efforts and the pace at which genomic medicine is evolving, the National Human 
Genome Research Institute assembled a working group: The Inter-Society Coordinating 
Committee for Physician Education in Genomics (ISCC-PEG). The ISCC-PEG’s mission 
statement is “to improve genomic literacy of healthcare providers and enhance the effective 
practice of clinical genomic medicine by facilitating interactions among key stakeholders in 
genomics education by identifying educational needs and potential solutions, sharing best practices 
in educational approaches, and developing educational resources.”77 In 2014, the ISCC was first 
tasked with developing a framework for genomics practice-based competencies for physicians.78 
Each practice-based competency falls under one of five entrustable professional activities (EPAs): 
Family History, Genomic Testing, Treatment Based on Genomic Results, Somatic Genomics, and 
Microbial Genomic Information. The competencies for each EPA are based on the six core 
competencies used by the Accreditation Counsel for Graduate Medical Education (ACGME) for 
medical residents in genomics: medical knowledge, patient care, interpersonal and 
communications skills, practice-based learning and improvement, professionalism, and systems-
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based practice. The ACGME broad competencies were in turn translated into core curriculum 
competencies for standard medical genetics education by the Association of Professors of Human 
and Medical Genetics (APHMG). The APHMG core curriculum utilizes deductive and empirical 
skills in genetics for the medical student as opposed to the memorization of symptoms associated 
with particular genetic diseases while also educating students on appropriate molecular genetic 
test selection, bioinformatics tools, and specialist referral.79 Most medical genetics course directors 
report using the APHMG core curriculum to guide and evaluate their own curriculum content.80 
2.8.3 Current Status of Genetics Education in Medical Schools 
There are a limited number of studies examining the curricula across medical schools 
nationwide. In 2005, 46% (52/112) of course directors and curricular deans reported that medical 
genetics was taught as a stand-alone course at their medical schools, and 54% (60/112) indicated 
that it was integrated into other courses, with most of these courses being taught in the first or 
second year.81 As evidenced by 80% of respondents indicating that these courses consisted of 
fewer than 40 contact hours, exposure to genetics education during medical school is limited.82 A 
minority of programs reported continuing genetics education into the third and fourth years. While 
genetics has advanced considerably in the past fifteen years, research has found that little has 
changed in the amount of time dedicated to genetics in medical school curriculum. A more recent 
study from 2013-2014 found similar trends in that most schools primarily teach genetics during 
the first 2 years, with an increase in the number of integrated curricula compared with a standalone 
medical genetics course.80 Only 26% of institutions reported formal genetics teaching during years 
3 and 4 of medical school. Interestingly, most medical genetics course directors from the 2013 
survey felt the amount of time spent on genetics was insufficient preparation for clinical practice.  
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Trends in the topics addressed during medical genetics have changed over time, with 
personalized medicine, direct-to-consumer testing, and pharmacogenomics being covered more 
frequently, whereas eugenics, linkage analysis, and evolutionary genetics have been removed from 
curriculum.80  
Certain institutions have attempted to tackle genetics education in unique and innovative 
ways. For example, Baylor College of Medicine recently began offering a “Genetics Track 
Curriculum” for medical students with a special interest in genetics. In addition to the standard 
curriculum, which includes 12 genetics education contact hours in Year 1 and 22 genetics 
education contact hours in Year 2, students are provided with additional didactic sessions, small 
group discussions, longitudinal clinical experiences, clinical and laboratory rotations, community 
outreach, and scholarly projects related to genetics.9 Other institutions and medical schools offer 
medical genetics “Special Interest Groups” (SIGs) to students interested in genetics.83 
Some medical schools have educated medical students on the benefits and pitfalls of 
personal genotyping considering the widespread availability of direct-to-consumer tests (DTC), or 
genetic tests that can be ordered at-will by a consumer without supervision from a healthcare 
provider. These tests typically involve a saliva sample with results made available online. The 
rapid growth of the direct-to-consumer testing market is remarkable, with up to 100 million people 
expected to undergo DTC testing by 2021.84 Consumers may be interested in DTC tests for a 
number of reasons, including but not limited to information regarding ancestry, lifestyle/fitness, 
entertainment, health information (i.e. the Jewish pathogenic BRCA1/2 variants), or access to raw 
genomic data files.85 
Direct-to-consumer tests have limited clinical utility in part because they are largely based 
upon single nucleotide polymorphism (SNP) genotyping rather than comprehensive whole gene 
 26 
sequencing.86 DTC results that are deemed clinically significant are recommended to have follow-
up diagnostic testing conducted through a health care provider. Contrary to the fact that DTC tests 
can be ordered without the oversight of a healthcare provider, companies offering DTC testing 
services often encourage discussing results with health care providers. Many patients view 
physicians as credible sources of information regarding their DTC test results, which raises the 
question of how physicians are equipped to handle these requests.87  
One study found that medical student perspectives on DTC testing shifted after taking a 
core genetics course that incorporated personal genotyping. After taking part in personal 
genotyping through the course, students were less likely to believe that information provided by 
DTC tests were useful in impacting medical management in terms of diagnosis and treatment of 
medical conditions, though many expressed that they would consider personal genotyping out of 
general curiosity.88 Additionally, approximately 50% of medical students who took part in 
personal genotyping expressed concern about confidentiality of results. While general genetics 
knowledge improved after taking the course, the students still struggled with clinical interpretation 
of DTC results when provided with scenarios.  
While many medical schools see the value in educating future physicians about genomics, 
there is the constraint of including additional content into an already rigorous and demanding 
curriculum. However, medical students have expressed a desire for additional genetics education 
given the integration of personalized genomic medicine into clinical care, with many expressing 
limited understanding of genomic concepts, reflected by low genetics knowledge scores.89 In 
response, certain programs have strived to provide unique educational experiences to maximize 
content retention.  One approach is to allow students to perform DNA sequencing on themselves 
using portable DNA sequencers to learn about next-generation sequencing (NGS).90,91 Discussion 
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about such results may result in improved genetic literacy, which is often incompletely attained 
during undergraduate education. Additionally, hands-on learning experiences using NGS 
technology appear to result in a greater willingness to learn how to interpret genetic test results 
and a greater appreciation of the patient experience.91 
2.8.4 Medical Genetics Education during Residency 
Some physicians receive additional training in genetics and genomics during residency, 
depending on their chosen specialty. However, even among medical students who choose to 
specialize in medical genetics, 32% had not taken a medical genetics elective prior to entering the 
medical genetics residency.92  
The Council on Resident Education in Obstetrics and Gynecology (CREOG) provides 
educational objectives for medical genetics education within an OB/GYN residency, which were 
last updated in 2020. Such topics include prenatal counseling, implications of genetic test results, 
knowledge of genes associated with hereditary cancer, and criteria for referral to a genetic 
counselor.93 One recent study reviewed OB/GYN residency programs’ websites during the month 
of December 2016. Out of 238 American Council for Graduate Medical Education (ACGME)-
accredited OB/GYN residency programs for which rotations schedules were publicly available, 
only 34 programs (14.3%) had a formal medical genetics and genomics education rotation.50 Out 
of these, only one program had a full month-long rotation dedicated entirely to medical genetics, 
whereas the other 33 were combined with another rotation, most commonly ultrasound. These 
observations challenge the assumption that medical students who pursue careers in specialties that 
rely on considerable genetics knowledge will receive thorough genetics training in residency. This 
has the potential to result in a limited understanding of genetics and its relationship to women’s 
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health , though interactive genetics curriculum during residency training has proven to be both 





Genetic literacy, a subset of health literacy, is defined as “sufficient knowledge and 
appreciation of genetics principles to allow informed decision-making for personal well-being and 
effective participation in social decisions on genetic issues”.11 The majority of the general 
population in the United States has not achieved genetic literacy.8,15,16 Though many Americans 
express familiarity with genetic terminology, few possess the fundamental scientific framework to 
contextualize genetic information in terms of their own health and medical management, resulting 
in a possible unintentional overestimation of understanding.13,17 Misconceptions about genetic 
testing rooted in limited genetic literacy have the potential to confound discussions concerning 
genetic information between patients and providers, a scenario which is becoming more common 
as genetics and precision medicine continues to become integrated into healthcare. Patient 
misunderstandings of genetic information have the potential to complicate diagnosis and treatment 
as well as diminish patient satisfaction, as patients with low genetic literacy are more likely to have 
poor information recall following a genetics-oriented conversation with a health care provider.16,25 
This puts the patient at increased risk for potentially problematic misconceptions of the natural 
history, surveillance, and treatment of their genetic condition, and may lead to over- or 
underestimations of the risk to other family members.26,27 
As genetics services become more routine, non-genetics affiliated healthcare providers 
(HCPs), most commonly oncologists and obstetricians/gynecologists (OB/GYNs), have ordered 
significantly more genetic tests as part of their practice.1,28 Given that many non-genetics HCPs 
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are likely to encounter patients in need of genetic counseling, it is important to consider what 
education HCPs receive concerning genetics and genetic testing, as well as who is involved with 
the provision of genetic services in healthcare. While there is a positive correlation between higher 
education, genetics knowledge, and a high degree of health literacy, even college-educated 
individuals are not always genetically literate, leading to concerns about the genetic literacy of 
healthcare providers themselves.11,18 There is a distinct connection between a provider’s genetic 
literacy and their clinical genetics knowledge; measuring a provider’s clinical genetics knowledge 
serves as a proxy for genetic literacy in an already health literate, highly educated population.  
Unfortunately, many HCPs, particularly physicians, report little formal genetics education 
and feel ill-prepared to discuss genetic information with their patients and interpret genetic test 
results.1,2,30 Up to one-third of genetic tests ordered by non-genetics healthcare providers were 
inappropriately ordered, either because they did not comply with practice guidelines, provided 
false reassurance to the patient, or failed to cover all involved differential diagnoses.63 Primary 
care physicians have cited a lack of knowledge about genetics and genetic risk assessment, concern 
for patient anxiety, and a lack of time both to counsel patients and to learn about genetic concepts 
as barriers to the integration of genetic services in primary care.34 Pediatricians have reported 
limited familiarity with genetic testing guidelines for children with common indications such as 
developmental delay, which affects between 1-3% of children.40-43 Similarly, the rollout of 
expanded carrier screening and expanded noninvasive prenatal testing (NIPT) has been 
complicated by a lack of provider education for OB/GYNs about counseling patients for the 
benefits, risks, and limitations of these tests.47-49  Evidence suggests that the genetic literacy of 
pregnant women does not impact their use of prenatal screening or diagnostic tests, yet providers 
may lack the ability to communicate the nuances of these tests to patients with limited genetic 
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literacy.51 Finally, numerous studies demonstrate limited knowledge of genes associated with 
hereditary cancers in many non-genetics healthcare providers, including but to a lesser degree 
oncologists.5,6,53 Many providers are familiar with BRCA1/2 but are unaware of other genes 
associated with hereditary forms of breast cancer, which often necessitates the need for multigene 
panel testing rather than testing only BRCA1/2 for many patients in accordance with NCCN 
guidelines.54 Inappropriate test selection for hereditary cancer may result in missed opportunities 
for preventative treatment, surveillance of at-risk relatives, and therapeutic opportunities such as 
the use of targeted therapies.2,10,55-57 
Physicians with limited formal genetics education are at increased risk of accidentally 
ordering the wrong genetic test, failing to refer a patient in need of genetic services, or 
unintentionally providing misinformation during results disclosure.3-6 These mistakes could result 
in harm to the patient and point toward the need for more physician training in selecting the 
appropriate genetic test, recognizing when referral to genetic services is necessary, as well as for 
utilization management through review of tests orders by a certified genetic counselor or genetics 
specialists. Unfortunately, workforce data on medical genetics specialists have revealed a stark 
contrast between the increasing demand for genetic testing and the number of available genetics 
providers. This current shortage of genetics specialists is exacerbated by the aging workforce of 
geneticists, the lack of applicants to genetics residency programs, and a lag in the supply of genetic 
counselors, which is not expected to equalize with demand until the late 2020’s.38,65-68 To 
communicate complex genetic information to patients with varying degrees of genetic literacy, our 
healthcare system needs not only more genetic counselors and geneticists, but also more 
genetically literate non-genetics healthcare providers to bridge the gap between patients and 
genetics specialists. 
 32 
As genomics continues to play a greater role in clinical care, non-genetics healthcare 
professionals will increasingly need to incorporate genetic concepts, such as inheritance patterns, 
family history, basic awareness of genetic conditions, and genetic testing into their practice. 
Consequently, medical schools will need to help medical students master these basic clinical 
genetics concepts. Since undergraduate education in biology largely focuses on molecular and 
Mendelian genetics, medical school is often a medical student’s first exposure to clinical 
genetics.12,75,76 The Association of Professors of Human and Medical Genetics (APHMG) core 
curriculum is used by many medical school genetics course directors, and utilizes deductive and 
empirical skills in genetics as opposed to the memorization of symptoms associated with particular 
genetic diseases while also educating students on appropriate molecular genetic test selection, 
bioinformatics tools, and specialist referral.79 However, most medical schools devote fewer than 
40 contact hours to genetics education, which studies have suggested is insufficient preparation 
for clinical practice.80-82 While many medical schools see the value in educating future physicians 
about genomics, there is the constraint of including additional content into an already rigorous and 
demanding curriculum. Though certain programs have strived to provide unique educational 
experiences to maximize content retention such as patient-led educational sessions, opportunities 
to join special interest groups, and even allowing students to perform direct-to-consumer testing 
on themselves, medical students have still expressed a desire for additional genetics education 
given the integration of genomic medicine into clinical care. 88,90,91  
Previous studies have shown that medical students have a limited understanding of 
genomic concepts, reflected by low genetics knowledge scores.89 This study is an updated 
assessment of current genetics educational exposures unique to the University of Pittsburgh School 
of Medicine with the goal of better understanding how students feel about their knowledge of 
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clinical genetics concepts through self-assessment, followed by a knowledge questionnaire. This 
and other studies are intended to provide additional evidence for the further integration of clinical 
genetics into medical school curriculum.  
3.1.1 Specific Aim I 
To develop a survey to assess the University of Pittsburgh medical students’ genetic 
literacy and clinical genetics knowledge as well as their familiarity with several clinical genetics 
topics. 
3.1.2 Specific Aim II 
To evaluate the process by which medical students acquire genetic knowledge during their 
training.  
3.2 Methods 
3.2.1 Study Population 
The target population for survey distribution consisted of all first year medical students at 
the University of Pittsburgh School of Medicine (UPSOM) during the 2020-2021 academic year. 
Students were eligible to take the survey if they had participated in the School of Medicine’s 
Human Genetics course during the Fall 2020 semester.  This 21-day course is required for all first 
year medical students at UPSOM.  
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3.2.2 Survey Development 
Prior to recruitment efforts and distribution, exempt IRB approval was obtained from the 
University of Pittsburgh (see Appendix B). The study was also approved by the University of 
Pittsburgh Research on Medical Students (ROMS) Committee (see Appendix C). The study survey 
was developed and distributed using the Qualtrics survey system, which was accessed through a 
University of Pittsburgh license. The survey included three major sections. The Self-Assessment 
section asked students to rate their familiarity and understanding of several clinical genetics topics 
on a 5-point Likert-scale. The Knowledge section was split into three portions: Inheritance, 
Clinical Genetics Scenarios, and Interpretation of Genetic Test Results. Questions within the 
Knowledge section were multiple choice questions with 3-4 possible responses and true/false 
questions. Finally, the UPSOM Human Genetics Course Assessment and Prior Experience in 
Genetics section asked participants about the perceived degree of difficulty of the UPSOM medical 
genetics course as well as any prior experience in the field of genetics.  
All survey questions (see Appendix E) were newly developed but were informed by 
instruments used in studies that surveyed similar student populations, specifically the Genetic 
Literacy Assessment Instrument (GLAI) developed by Bowling et al, the International Genetic 
Literacy and Attitudes Survey (iGLAS), Ormond et al.’s study concerning direct-to-consumer 
genetic testing, and Pearl et al.’s study involving knowledge assessment of a medical school’s 
clinical neurogenetics curriculum.11,19,88,89 Confidence topics were derived from questions in 
Bowling et al and iGLAS since these studies target the general population. Clinical knowledge 
questions were generated based on questions presented in Ormond et al and Pearl et al, both of 
which are focused on the opinions of medical and graduate students. In developing the survey, 
multiple physicians and genetic counselors were consulted for input on perceived gaps in genetics 
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education of medical students. Survey questions ascertained knowledge on prenatal, pediatric, and 
cancer genetics and covered content that was included in the UPSOM Human Genetics course. 
Survey questions were reviewed for clarity by four genetic counselors, an MD, and a statistical 
geneticist. The survey was piloted by 10 genetic counseling students.  Based upon their feedback, 
minor modifications to the wording of several questions were made for clarity. 
3.2.3 Recruitment and Survey Distribution 
Survey distribution was facilitated by a contact within the University of Pittsburgh School 
of Medicine Office of Education (OME). The study coordinator contacted this individual in 
advance of the survey distribution and provided the survey invitation (see Appendix D). The OME 
contact sent the survey invitation to all email addresses belonging to current first year medical 
students at the University. The survey opened to participants on February 5, 2021 and concluded 
on March 5, 2021. A reminder email was sent to the students on February 23, 2021. Data was 
collected anonymously through the Qualtrics survey system. 
3.2.4 Statistical Methods 
Descriptive statistics were used to indicate how frequently each response was selected. 
Microsoft Excel and Qualtrics were used to generate descriptive statistics. Composite scores for 
Likert scale Self-Assessment questions were generated to assess confidence with various genetic 
concepts. Similarly, composite scores were generated in the knowledge section. Nonparametric T-
tests (Wilcoxon rank-sum) were used to study the association between knowledge, confidence, 
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and prior experience. P-values under 0.05 were considered statistically significant. Stata statistical 
software (Version 16) was used for all statistical analyses.  
3.3 Results 
3.3.1 Response Rate 
The survey was distributed to 147 first year medical students at the University of 
Pittsburgh. We received 21 total responses, yielding a response rate of 14.3%. However, only 15 
participants completed the Self-Assessment. The six incomplete responses who did not complete 
the Self-Assessment were excluded from all analyses. Two participants started but did not 
complete the Knowledge Assessment. Only 10 participants completed the entire survey, yielding 
a response rate of 6.8%.  
3.3.2 Self-Assessment of Knowledge  
Participants were asked to rate their knowledge in twelve genetic concepts. The statements 
used were positively framed, i.e. “I can do this task” or “I am knowledgeable in this concept” and 
were assessed using a 5-point Likert scale (1=strongly disagree; 5= strongly agree). Responses 
were used to generate composite scores to yield a total maximum “confidence score” of 60. The 
term “confidence” or “confidence score” is a measure of the student’s perceived knowledge or 
ability to perform a skill related to a clinical genetics concept. For the fifteen respondents who 
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completed the Self-Assessment, the average confidence score was 47.93/60 (79.8% confident) (see 
Appendix A: Table 7.  
Table 1 shows the responses for the fundamental genetic concepts portion of the Self-
Assessment. 81% of respondents (n=13/15) answered “Strongly Agree” in rating their knowledge 
of the central dogma and inheritance. Participants also reported a high level of understanding of 
population genetics (93% “Strongly” or “Somewhat” agree; n=14/15). With regards to molecular 
and cytogenetic techniques, only one respondent felt strongly confident in their knowledge, with 
66% of respondents somewhat agreeing and 26% neither agreeing nor disagreeing.  
 
Table 1. Self-Assessment: Fundamental Genetic Concepts
 
 
Responses were more variable for self-assessment of clinical skills (see Table 2). 87% of 
participants (n=13/15) “agreed” or “somewhat agreed” that they were capable of taking a family 
history for a genetics indication, while 73% “agreed” or “somewhat agreed” (n=11/15) that they 
Genetic Concept Number of Participants (N=15)
I understand the relationship between DNA, RNA, and protein.
Strongly agree 13
Somewhat agree 1
Neither agree nor disagree 0
Somewhat disagree 0
Strongly disagree 1
I understand the foundational concepts of genetic inheritance.
Strongly agree 13
Somewhat agree 1
Neither agree nor disagree 0
Somewhat disagree 0
Strongly disagree 1
I understand how ancestry, genetic drift, and natural selection relate to modern patient populations.
Strongly agree 9
Somewhat agree 5
Neither agree nor disagree 0
Somewhat disagree 0
Strongly disagree 1
I am knowledgeable about the principles of cytogenetics and molecular genetic techniques.
Strongly agree 1
Somewhat agree 10




felt confident enough to assess risk for a genetic condition based on a family history. Only 60% 
(n=9/15) felt comfortable or somewhat comfortable identifying indications for referral to a 
genetics specialist. Knowledge of clinical genetics resources was varied; 53% of respondents 
(n=8/15) were not familiar with clinical genetics resources or databases. Participants rated their 
ability to describe the benefits, risks, and limitations of genetic testing positively (87% “Strongly” 
or “Somewhat” agree; n=13/15). 
 
Table 2. Self-Assessment: Genetic Concepts Involving Clinical Skills
 
Genetic Concept Number of Participants (N=15)
I can gather a detailed family history for a genetic indication.
Strongly agree 3
Somewhat agree 9
Neither agree nor disagree 1
Somewhat disagree 2
Strongly disagree 0
I can assess genetic risk based on the information within a family history.
Strongly agree 4
Somewhat agree 7
Neither agree nor disagree 0
Somewhat disagree 3
Strongly disagree 1
I am comfortable identifying indications for referral to a genetics specialist.
Strongly agree 3
Somewhat agree 6
Neither agree nor disagree 4
Somewhat disagree 2
Strongly disagree 0
I can apply knowledge of genetic principles to effectively communicate with patients who have limited genetic literacy.
Strongly agree 8
Somewhat agree 4
Neither agree nor disagree 2
Somewhat disagree 0
Strongly disagree 1
I am familiar with clinical genetics resources and databases.
Strongly agree 2
Somewhat agree 5
Neither agree nor disagree 3
Somewhat disagree 3
Strongly disagree 2
I can describe the benefits, risks, and limitations of genetic testing to a patient.
Strongly agree 7
Somewhat agree 6




Lastly, Table 3 shows that 66% of respondents (n=10) rated their knowledge of genetics 
and genetic testing in relation to cancer positively. Participants ranked their knowledge higher for 
methods of prenatal diagnosis (87% “Strongly” or “Somewhat” agree; n=13/15). 
 
Table 3. Self-Assessment: Cancer and Prenatal Genetic Concepts 
 
3.3.3 Clinical Genetics Knowledge 
In the next section of the survey the participants were assessed on their knowledge of 
clinical genetics. The average score of all participants for the Clinical Genetics Knowledge section 
was 72.1%, or 13.7 questions correct out of 19 total knowledge questions. The Clinical Genetics 
Knowledge section was divided into three portions: Inheritance (six questions), Clinical Genetics 
Scenarios (eight questions), and Interpretation of Genetic Test results (five questions). The 
comparison between knowledge composite scores and self-assessment composite scores are shown 
in Figure 1. There is a positive correlation (R = 0.61 between knowledge and confidence. However, 
this relationship is not as strong after censoring a high leverage point. After removing this datapoint 
(knowledge score=10, confidence score=16), the correlation is considerably weaker (R=0.04), 
which may point to limitations in this study, which will be addressed in the Discussion section.  
Genetic Concept Number of Participants (N=15)
I have thorough knowledge of genetics relating to the development, diagnosis, and treatment of cancer.
Strongly agree 4
Somewhat agree 6
Neither agree nor disagree 3
Somewhat disagree 1
Strongly disagree 1
I am aware of methods for prenatal diagnosis of genetic conditions.
Strongly agree 7
Somewhat agree 6




Figure 1. Comparison of Genetics Knowledge and Confidence Scores
 
Maximum Knowledge Score = 19; Maxiumum Confidence Score = 60 
 
Table 4 outlines the frequency of correct responses for questions concerning inheritance. 
All participants (n=12) correctly answered questions asking them to identify characteristics of 
autosomal recessive and mitochondrial inheritance. Similarly, most participants (91.67%) knew 
that for multifactorial conditions, when a phenotype is more common in one sex, the risk for having 
the phenotype is higher for relatives of an affected individual of the less susceptible sex. However, 
only 8 respondents (66%) were able to correctly identify the carrier risk for a healthy child whose 
sibling has an autosomal recessive condition (a 66% carrier risk); 4 respondents (33%) incorrectly 
stated that the sibling’s carrier risk would be 50%. When asked about characteristics of X-linked 
recessive inheritance, only 7 (58.3%) participants correctly indicated that the children of affected 
males are typically not at risk for being affected with the condition; 4 (33.33%) respondents 
incorrectly reported that females are usually more severely affected than males and 1 (8.33%) 




















Assessment of Genetics Knowledge and Confidence
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encountered difficulty with a scenario involving autosomal dominant inheritance. When asked 
what the chance for a male with deletion of the 22q112 region, also known as DiGeorge syndrome, 
to have a child with this same condition, only 7 (58.3%) participants correctly indicated that each 
child would have a 50% chance to inherit the deletion; 3 (25%) respondents incorrectly reported 
that the child’s risk would be 25% and 2 (16.67%) respondents thought that the risk would be less 
than 1%.  
 
Table 4. Knowledge Assessment (Inheritance): Frequency of Correct Responses   
Inheritance 





What is the chance that a healthy child whose sibling has an 
autosomal recessive genetic condition will be a carrier? 
8 (66.67%) 34-90% 
A woman marries her 1st cousin, once-removed. Which 
scenario is most likely? 
12 (100%) - 
Select the statement that best describes X-linked recessive 
inheritance: 
7 (58.33%) 28-85% 
True or False: For multifactorial conditions, when a 
phenotype is more common in one sex, the risk for having 
the phenotype is higher for relatives of an affected 
individual of the less susceptible sex. 
11 (91.67%) 62-99% 
What is the chance for a male with deletion of the 22q11.2 
region, otherwise known as DiGeorge syndrome, to have a 
child with this same condition? 
7 (58.33%) 28-85% 
A pregnant woman comes for genetic counseling because 
the father of her female fetus has Leber's hereditary optic 
neuropathy (LHON), a mitochondrially inherited genetic 
condition. What is the chance that this fetus is affected with 
LHON? 
12 (100%) - 
Note: 12 respondents completed the Inheritance section. 
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The first portion of the Clinical Genetics Scenarios section (see Table 5) elicited 
respondents’ knowledge relating to cancer genetics, with three out of four questions concerning 
the BRCA1/2 genes.  The first scenario references a female patient with breast cancer who reports 
that she has undergone genetic testing and was found to have “the gene for breast cancer" but is 
implied to not have a copy of the genetic test report. Participants were expected to not rely solely 
on the patient’s statement, however, all participants (n=9) selected that it would be reasonable to 
assume that the patient has a pathogenic variant in a gene associated with an increased risk for 
breast cancer, even without a copy of the report. Many participants (90.91%) indicated the 
counseling for a familial BRCA1 pathogenic variant would include a discussion about lifestyle 
modification, surgical recommendations, and psychosocial concerns, as well as potential referral 
to a high-risk breast cancer screening program. In a related scenario where an unaffected 30-year-
old woman comes to the genetics clinic for BRCA1 and BRCA2 testing, only 4 participants 
(36.36%) correctly selected the patient’s mother, who had breast cancer diagnosed at age 40, as 
the best person to test; all other participants (n=7; 63.64%) stated that the patient should be tested 
first. When asked about testing a child for an adult-onset hereditary cancer syndrome, 8 
participants (72.73%) correctly said that genetic testing would typically not be recommended until 
the child is a legal adult.  
Questions concerning pediatric scenarios focused on genetic testing strategy. Only 4 
participants (36.36%) correctly stated that microarray should be the first genetic test to order for a 
5 year old girl with dysmorphic features, developmental delay, and microcephaly; 5 respondents 
(45.45%) would have ordered Chromosome Breakage studies (DEB analysis) and 2 (18.18%) 
would have ordered exome sequencing. Similarly, while participants recognized that it would be 
appropriate to order a karyotype when there is suspicion for Down syndrome, 5 participants 
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(45.45%) felt that it would not be necessary to order a karyotype if there was concern for a 
translocation due to a history of multiple miscarriages and 1 participant (9.09%) felt that it would 
not be necessary to order a karyotype when there was concern for a sex chromosome disorder. 
Regarding the prenatal scenarios, 9 participants (81.82%) would use counseling strategies 
to individually explore a couple’s thoughts about the outcomes of their pregnancy following a 
prenatal diagnosis of Klinefelter syndrome; 2 participants (18.18%) felt it would be necessary to 
first provide detailed information about the features of Klinefelter syndrome. All participants 




Table 5. Knowledge Assessment (Clinical Genetics Scenarios): Frequency of Correct Responses 
Clinical Genetics Scenarios  





A female patient with breast cancer reports that she has undergone 
genetic testing and was found to have the "gene for breast cancer". 
Which of the following is safe to assume based solely on the patient's 
statement? 
0 (0%) - 
A 21 year old woman reports that her mother had a BRCA1 mutation 
and provides you with the report confirming this information. She is 
unwilling to undergo genetic testing at this stage in her life, but is 
fearful of developing cancer. How do you counsel this patient? 
10 (90.91%) 59-99% 
A 30 year old woman comes to the genetics clinic for BRCA1 and 
BRCA2 testing. She does not have breast cancer, but her mother was 
diagnosed with breast cancer at age 40, her maternal female first 
cousin was diagnosed with breast cancer at age 35, and her paternal 
aunt was diagnosed with breast cancer at age 65. To clarify the 
woman's risk, which of the following individuals should be tested 
first? 
4 (36.36%) 11-69% 
A woman with hereditary nonpolyposis colorectal cancer, otherwise 
known as Lynch syndrome, wants her 14 year old daughter to be 
tested for the known familial mutation. What do you tell this woman 
and her daughter? 
8 (72.73%) 39-94% 
A 5 year old girl presents to your clinic with dysmorphic features, 
developmental delay, and microcephaly. Which of the following is the 
most appropriate genetic test to order for this child? 
4 (36.36%) 11-69% 
When is it LEAST appropriate to order a karyotype? 5 (45.45%) 17-77% 
A woman is referred to your clinic at 19 weeks gestation because her 
amniocentesis, performed for advanced maternal age, revealed a 
karyotype of 47,XXY (Klinefelter syndrome). The woman and her 
partner are tearful, and are debating whether to terminate the 
pregnancy. How would you discuss this result with the couple? 
9 (81.82%) 48-98% 
True or False: Non-Invasive Prenatal Testing (NIPT) has a very high 
detection rate for Down syndrome, therefore, diagnostic testing is not 
needed following a positive NIPT. 
11 (100%) - 
Note: 11 respondents completed the Clinical Genetics Scenarios section. 
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The Interpretation of Genetic Test Results section, shown in Table 6, asked participants to 
interpret genetic test results for a variety of genetic conditions. 80% of participants correctly stated 
that a child with a positive newborn screen for cystic fibrosis with a negative sweat test and a 
single F508 mutation is a carrier for cystic fibrosis, while 20% suspected that the child would have 
CFTR-Related Metabolic Syndrome (CRMS). 6 participants (60%) stated that the parents of a 
child with a confirmed de novo 22q11.2 deletion would have a slightly increased risk to have 
another child with DiGeorge syndrome due to the possibility of germline mosaicism, while 4 
participants (40%) would have told the parents that they were not at increased risk. The majority 
of participants (8 participants; 80%) correctly stated that medical management decisions should 
typically not be made based on a variant of unknown significance. If one had clinical suspicion 
that a variant of uncertain significance had clinical meaning, 3 participants (30%) correctly stated 
that they would test other affected family members to see if the variant tracks with the phenotype 
of interest in the family; the other 70% of participants would have also repeated the test or tested 
other tissue types, both of which are costly and unnecessary measures. All participants (n=10) 
were correct in associating increased nuchal translucency on ultrasound with being a soft marker 




Table 6. Knowledge Assessment (Interpretation of Genetic Test Results): Frequency of Correct Responses 
Interpretation of Genetic Test Results 





A couple whose child had a positive newborn screen for 
cystic fibrosis presents to your clinic for counseling. The 
child's sweat test returns negative and genetic testing 
reveals one mutation: a F508 deletion. What do these 
results mean for the child? 
8 (80%) 44-97% 
An infant with deletion of the 22q11.2 region, otherwise 
known as DiGeorge syndrome, is evaluated by medical 
genetics. Neither of the child's parents carry the deletion. 
The parents are interested in having more children and 
want to know their risk of having another affected child. 
What information would you provide when discussing 
recurrence risk for future pregnancies? 
6 (60%) 26-88% 
A genetic test report reveals a "variant of unknown 
significance". What does this result mean for the patient? 
8 (80%) 44-97% 
Which of the following methods can be used to determine 
the clinical meaning of a variant of uncertain significance? 
3 (30%) 7-65% 
If a fetus has an increased nuchal translucency, which of 
the following karyotype results is the most likely to be 
found on amniocentesis? 
10 (100%) - 
Note: 10 respondents completed the Interpretation of Genetic Test Results section. 
 
3.3.4 UPSOM Human Genetics Course Assessment and Prior Experience in Genetics 
Participants were asked to provide information concerning UPSOM’s Human Genetics 
course. Seven participants (70%) reported that the course was moderately challenging, while the 
other 3 participants reported that it was slightly challenging. Eight participants (80%) learned “a 
moderate amount” to “a lot” from the course and 2 participants only learned “a little”.  
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The majority of participants (8/10, 80%) reported that they took a genetics course during 
their undergraduate education. Participants were asked to state if they had any prior work 
experience in genetics, which was defined as any laboratory position, research, clinical 
observation, and paid positions relevant to genetics. Four participants reported prior work 
experience in genetics, which included genetics-based research in molecular genetics, 
immunology, and infectious disease, as well as multiple undergraduate genetics courses. One 
participant reported prior work in a clinical setting where genetics was relevant. The other 6 
participants reported no prior work experience.  
To analyze the knowledge of the participants, a nonparametric t-test was performed to 
show the differences in self-assessment and knowledge scores between respondents who had prior 
work experience in genetics and those who did not. There was no statistically significant difference 
between confidence scores for respondents with prior work experience in genetics and those who 
did not (p = 0.4542). Similarly, there was no statistically significant difference between knowledge 
scores for respondents with prior work experience in genetics and those who did not (p = 0.8201). 










This survey of medical students noted discrepancies between student’s overall confidence 
and knowledge. The average confidence score was 47.93/60 (79.8% confident), while the average 
score for the Clinical Genetics Knowledge section was 72.1%, or 13.7 questions correct out of 19 
total knowledge questions. Per personal communication with the course director of the University 
of Pittsburgh Human Genetics course, the medical students generally score around the 80th 
percentile on examinations (S Khan 2021, personal communication, 9 April). A 7.9% difference 
between confidence and knowledge, while not a large discrepancy, suggests that medical students 
may be somewhat overconfident in their knowledge of genetics concepts.  
Overconfidence in genetic knowledge has been observed in physicians, with one study 
finding that despite confusion surrounding interpretation of genetic tests and implications for 
medical management, up to 61% of non-genetics healthcare providers had a positive attitude 
towards their knowledge of genetic testing options for hereditary cancer.3 In contrast, many 
physicians have reported feeling ill-prepared to discuss genetic information with their patients, 
particularly in the context of counseling patients, selecting an appropriate test, and knowing the 
guidelines for a genetics referral.1,2  
Most participants were confident in their knowledge of fundamental concepts involving 
molecular genetics and inheritance, but the Self-Assessment of clinical genetics skills section 
responses varied. 87% of participants reported feeling confident in their ability to take a family 
history and 73% indicated that they felt confident enough to assess risk for a genetic condition 
based on a family history. These results are discrepant with the findings of a study of primary care 
providers that utilized a standardized patient roleplay involving a case of early-onset breast cancer. 
Wilkes et al. found that primary care providers infrequently performed key counseling behaviors 
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related to inherited breast cancer such as taking the family history of cancer, including asking 
about the age of onset of breast cancer, which diminishes their ability to perform a proper risk 
assessment and represents limited familiarity with the utility of these skills.35 Respondents to this 
survey felt confident taking a family history and performing a risk assessment which is likely 
influenced by the fact that these students recently completed coursework in genetics, but 
conversely may represent overconfidence in their abilities.  
Only 60% of respondents felt comfortable identifying indications for referral to a genetics 
specialist and only 47% expressed confidence in their familiarity with clinical genetics resources. 
These findings are consistent with previous studies of medical students, which found that only half 
were familiar with the Online Mendelian Inheritance in Man (OMIM) database, a commonly used 
tool for any genetics specialist.89 The Association of Professors of Human and Medical Genetics 
(APHMG) core curriculum currently recommends that all medical students should be able to 
obtain reputable current information about genetics online using websites such as OMIM, National 
Human Genome Research Institute (NIH/NHGRI), and MedlinePlus (formerly Genetics Home 
Reference).79 These findings are also consistent with the notion that physicians often do not refer 
patients for genetic counseling due to uncertainty of when it is appropriate to refer and that this 
uncertainty is rooted in physicians’ limited clinical genetics knowledge in conjunction with a lack 
of awareness of clinical genetics resources, including clinical guidelines, and tools to help make 
appropriate decisions regarding their patient’s medical management. For example, the genetic 
counseling referral rates for women with epithelial ovarian cancer vary widely between medical 
centers and referral rates are especially low in the case of rare cancers, such as male breast 
cancer.55,59-61 While up to 74% of non-genetics health professionals are familiar with web-based 
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cancer risk assessment models, additional training on cancer risk assessment and the utility of these 
models is desired.53,82  
Participants correctly answered questions about characteristics of autosomal recessive, 
multifactorial, and mitochondrial inheritance, but may have encountered difficulty in calculating 
carrier risks, with 33% of respondents incorrectly stating that a healthy child whose sibling has an 
autosomal recessive genetic condition would have a 50% chance of being a carrier, rather than 
66% (66.67% correctly answered; 95% CI 34-90%). Additionally, there may have been confusion 
surrounding characteristics of X-linked recessive inheritance, with 7 (58.3%; 95% CI 28-85%) 
participants correctly indicating that the children of affected males are typically not at risk for 
being affected with the condition; 4 (33.33%) respondents incorrectly reported that females are 
usually more severely affected than males and 1 (8.33%) respondent thought that males and 
females would be affected equally.  
Studies have suggested that physicians demonstrate knowledge of autosomal dominant 
inheritance through familiarity with the BRCA genes.5 This familiarity in theory would aid a 
physician in assessing risk for other conditions following autosomal dominant inheritance in the 
clinic. However, these results show that students may not recognize more nuanced examples of 
autosomal dominant inheritance. For example, 41.7% of respondents failed to recognize that 
chromosomal deletions follow autosomal dominant inheritance, therefore the recurrence risk of a 
chromosomal deletion or duplication, with one chromosome altered and the other intact, would be 
50%. Information about the clinical characteristics of the specific deletion or duplication was 
irrelevant in this context. Similarly, 60% of participants correctly stated that the parents of a child 
with a confirmed de novo 22q11.2 deletion would have a slightly increased risk to have another 
child with DiGeorge syndrome due to the possibility of germline mosaicism, while 40% of 
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participants would have told the parents that they were not at increased risk. While respondents 
were confident in their understanding of inheritance (81% answered “Strongly Agree” in rating 
their knowledge of inheritance), based on the responses to knowledge scores it appears there 
remains a need for improved education regarding risk assessment, chromosomal conditions, and 
X-linked inheritance. 
Respondents were given a scenario where a female patient with breast cancer reports that 
she has undergone genetic testing and was found to have “the gene for breast cancer" but is implied 
to not have a copy of the genetic test report. Participants were expected to not rely solely on the 
patient’s statement, however, all participants (n=9) selected that it would be reasonable to assume 
that the patient has a pathogenic variant in a gene associated with an increased risk for breast 
cancer, even without a copy of the test report. It is worth considering that medical students may be 
overestimating a patient’s genetic literacy, however, this may also reflect poor wording of the 
survey question. 
Respondents also encountered difficulty with identifying the best individual in a family to 
test for a familial variant. In a scenario where an unaffected 30-year-old woman comes to the 
genetics clinic for BRCA1 and BRCA2 testing, only 4 respondents (36.36%) correctly selected the 
patient’s mother, who had breast cancer diagnosed at age 40, as the best person to test; the other 
respondents (63.64%) stated that the patient should be tested first. This confusion over genetic 
testing strategy has been identified in research with physicians. One study found that in families 
with known pathogenic variants, where single-site testing of BRCA1/2 would be appropriate, fewer 
than 35% of physicians correctly ordered single-site testing and instead ordered comprehensive 
BRCA analysis or panel testing, resulting in excess medical costs to the patient.58 Reassuringly, a 
majority of participants in this study (90.91%) indicated that counseling for a familial BRCA1 
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pathogenic variant would include a discussion about lifestyle modification, surgical 
recommendations, and psychosocial concerns, as well as potential referral to a high-risk breast 
cancer screening program, suggesting that medical students recognize that identification of a 
hereditary cancer syndrome involves comprehensive counseling and management.  
The majority of participants (8 participants; 80%) correctly stated that medical 
management decisions should typically not be made based on a variant of unknown significance, 
a response consistent with the joint recommendations of the American College of Medical 
Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP).64 In 
contrast, studies reveal confusion surrounding medical management decisions and variants of 
uncertain significance by physicians.2,5,41,58  One study found that when presented with a case of a 
BRCA1 variant of uncertain significance, 82% of physicians recommended testing of at-risk 
relatives and 13% recommended oophorectomy for the affected patient based on the VUS, with 
no statistically significant difference between physicians with and without prior BRCA1/2 testing 
experience.57 In some cases however, particularly in the pediatric setting, laboratories may offer 
to perform family studies to assist the lab in future classification of the variant. When asked about 
approaches to determining the clinical meaning of a variant of uncertain significance, 3 
participants (30%) correctly stated that they would test other affected family members to see if the 
variant tracks with the phenotype of interest in the family; the other 70% of participants would 
have also repeated the test or tested other tissue types, both of which are costly and unnecessary 
measures that would still yield inconclusive results. 
Several survey questions addressed pediatric genetic testing. While ACMG recommends 
microarray as the first-line genetic test for any child with dysmorphic features or developmental 
delay, 95 only 4 participants (36.36%) correctly stated that microarray should be the first genetic 
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test to order for a child with dysmorphic features, developmental delay, and microcephaly. Instead, 
respondents favored Chromosome Breakage studies (DEB analysis) or exome sequencing. While 
it may one day be feasible to implement exome as the first genetic test for children with this 
phenotype, at this time, exome is often cost-prohibitive and not the recommended first-line genetic 
test. The respondents’ answers are consistent with studies indicating that there is confusion 
surrounding testing strategy among non-genetics healthcare providers. One survey from 2018 
identified that 68% of pediatricians were not familiar with any genetic testing guidelines for a 
patient with global developmental delay (GDD), signifying that genetic testing guidelines are not 
well disseminated, particularly if they are issued by other specialties.41 Of those 31.9%, most were 
familiar with the American Academy of Pediatrics (AAP) recommendations The AAP 
recommendations were the most well-known: 27% were familiar with AAP recommendations 
whereas only 2.8% were familiar with the American College of Medical Genetics and Genomics 
(ACMG) guideline on cytogenetic tests. Similarly, while participants recognized that it would be 
appropriate to order a karyotype if there is suspicion for Down syndrome, 5 participants (45.45%) 
felt that it would not be necessary to order a karyotype when there was concern for a translocation 
due to a history of multiple miscarriages and 1 participant (9.09%) felt that it would not be 
necessary to order a karyotype if there was concern for a sex chromosome disorder. These findings 
suggests that there is possible confusion surrounding the nature of chromosomal conditions and 
the type of information gained from a karyotype.  
The majority of respondents (81.82%) would use counseling strategies to individually 
explore a couple’s thoughts about the outcomes of their pregnancy following a prenatal diagnosis 
of Klinefelter syndrome. Two participants (18.18%) felt it would be necessary to first provide 
detailed information about the features of Klinefelter syndrome. While information about the 
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genetic condition is important, a provider should first assess the parents’ emotional state and avoid 
overwhelming them by going into too much medical or technical detail. All participants were 
correct in recognizing increased nuchal translucency on ultrasound as being a soft marker for 
Down syndrome. The respondents’ confidence and generally high knowledge scores on topics 
concerning prenatal genetics may reflect good coverage of these topics during the Human Genetics 
course, as well as possible utilization of knowledge from other courses.  
Among the 10 respondents to complete this survey, 8 reported having taken a genetic 
course during their undergraduate education. Four respondents, one of who did not take a genetics 
course during their undergraduate education, reported prior work experience in genetics, which 
included genetics-related laboratory research and genetics related work in a clinical setting. There 
was no statistically significant difference between confidence scores for respondents with prior 
work experience in genetics and those who did not. Similarly, there was no statistically significant 
difference between knowledge scores for respondents with prior work experience in genetics and 
those who did not. These findings suggest that all medical students, even those who report prior 
genetics work experience in a research setting, would benefit from learning the breadth of both 
molecular and clinical genetics in medical school curriculum.  Additionally, the small sample size 
may have negatively affected the chance of detecting statistically significant results (or 
relationships). 
In 2005, most medical schools devoted fewer than 40 contact hours to genetic education.81 
A more recent study from 2013-2014 found that the mean number of total genetics contact hours 
for medical students is 36 hours, with 75% of medical school genetics course directors reporting 
that genetics education is integrated into other courses such as biochemistry, metabolism, or 
cellular biology.80 The University of Pittsburgh School of Medicine Human Genetics course 
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provides students with 44 contact hours of genetics education, which includes both lectures and 
interactive patient-led educational sessions. Respondents were given the opportunity to write in 
suggestions to improve UPSOM’s Human Genetics course and topics they would like to focus on. 
Suggestions included more discussion of recommended changes to medical management based on 
genetic test results and additional patient-led educational sessions. Respondents reported that they 
are most interested in cancer genetics, prenatal genetics, and personalized medicine, which 
suggests that they view genetics as being essential to future practice as a physician in their chosen 
specialty, rather than a tangential field for specialists. 
3.4.1 Study Limitations 
This study had several limitations, with the most important being the low response rate. 
The low number of respondents only allowed for a limited analysis. No statistically significant 
findings were identified and the small sample may have adversely impacted the chance to identify 
statistically significant relationships. Therefore, this survey may not reflect the knowledge and 
opinions of all University of Pittsburgh medical students. The survey was intentionally distributed 
more than three months after the Human Genetics course concluded to observe retention of 
knowledge, however the timing of the survey may have conflicted with the medical student’s busy 
schedule and resulted in the low participation rate. Additionally, participation may have been 
compromised due to the challenges medical students are currently facing during COVID-19 
pandemic. 
Selection bias may be present within this study design. Given the lack of compensation for 
participation in the survey, the language in the survey recruitment may have inadvertently attracted 
two distinct groups of participants: those with a strong interest in genetics and/or those with 
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previous genetics experience, and those who were frustrated with their experience in the Human 
Genetics course. Individuals are more likely to take surveys pertaining to topics that they are 
interested and proficient in, which may result in higher estimates of confidence and knowledge.96 
In theory, individuals who may not have performed well in the Human Genetics course may have 
chosen to participate to demonstrate their lack of confidence or knowledge; this may explain the 
one high leverage datapoint in the dataset.  
Survey questions were designed to be relevant to the Human Genetics course material and 
timeless given the ever-changing nature of the field of clinical genetics. In hindsight, a few of the 
knowledge questions could have been constructed in a different way to better satisfy these criteria. 
For example, one question referenced a 5-year-old girl who presents with dysmorphic features. 
According to current practice guidelines, the correct answer regarding genetic testing for this 
clinical scenario is microarray. However, as the cost and availability of whole exome sequencing 
(WES) improves, WES may one day replace microarray as the first-line test for this particular 
indication. To keep the survey questions timeless, it may be worth reexamining this question. 
Another question asked about an adult-onset hereditary cancer syndrome. This syndrome was 
discussed in the student’s Human Genetics course, but only briefly. While the intent of the question 
was for students to recognize that genetic testing for adult-onset conditions in children is not 
recommended, the Human Genetics course manual did not explicitly mention that this condition 
was adult-onset, which may have led to several participants thinking that it would be appropriate 
to test a child in this scenario. In another question, respondents were given a scenario where a 
female patient with breast cancer reports that she has undergone genetic testing and was found to 
have “the gene for breast cancer" but is implied to not have a copy of the genetic test report. 
Participants were expected to not rely solely on the patient’s statement, however, all participants 
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(n=9) selected that it would be reasonable to assume that the patient has a pathogenic variant in a 
gene associated with an increased risk for breast cancer, even without a copy of the test report. In 
this scenario, a copy of the genetic test report is necessary to confirm that the patient has a 
pathogenic variant, not a variant of uncertain significance, and to determine which of the many 
genes associated with breast cancer the patient is referring to prior to coordinating management 
and testing of relatives. It is worth considering that medical students may be overestimating a 
patient’s genetic literacy, however, this may reflect poor wording of the survey question. Since the 
survey did not contain any questions about direct-to-consumer (DTC) genetic testing, this 
particular question could be replaced by a question that addresses a positive DTC test with the goal 
of gauging participant’s knowledge about the clinical utility of DTC testing.  
There was also significant dropout among participants after the Self-Assessment. Those 
who dropped out upon seeing the Knowledge section may have faced greater time constraints than 
those able to complete the entire survey. Of course, the Knowledge section requires considerable 
problem-solving skills and information recall, which given medical student’s busy schedules, may 
have required more time than students were willing to dedicate to complete the survey. Our hope 
is that this survey can be utilized in future research. To combat the issue of low response rate, we 
would advise future researchers to compensate students in some manner for completing the survey.  
3.4.2 Future Directions 
This survey was distributed three months following the conclusion of the Fall 2020 Human 
Genetics course with the goal of getting preliminary data on long-term clinical genetics content 
retention. Now that the survey has been both piloted and distributed once, certain questions can be 
modified to capture knowledge more accurately for the purpose of future research.  We hope to 
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continue this study through distributions to future cohorts of medical students as part of a 
longitudinal study. One potential study design would be to incorporate the survey into the students’ 
Human Genetics course. The survey could be distributed twice to the same cohort to obtain both a 
pre-course response and immediate post-course response. This cohort could be followed 
throughout their training while tracking their personal experiences in clinical genetics. At the 
University of Pittsburgh, certain medical students will get additional genetics coursework through 
elective coursework and clinical experiences during rotations in their third and fourth years. This 
study design will ideally show an evolution of a medical student’s understanding of clinical 
genetics and genetic testing as they complete coursework, however it is possible that gaps in the 
trainee’s knowledge will still be observed. It could also contribute to the analysis of curricular 
changes over the course of the next few years that is taking place at the University of Pittsburgh 
School of Medicine. 
3.5 Conclusion 
The confidence and clinical genetics knowledges of medical students was assessed using a 
questionnaire which asked them to rate their confidence in their knowledge of clinical genetics 
concepts and answer knowledge questions concerning clinical genetics that the students may 
encounter in future practice as physicians. Overall, the students were confident in their perceived 
knowledge of clinical genetics concepts. However, the knowledge assessment revealed that 
students often incorrectly answered knowledge questions pertaining to clinical genetics concepts 
which received higher confidence scores, namely inheritance and risk assessment. This suggests 
that students may be somewhat overconfident in their knowledge in certain areas. Students 
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reported lower confidence scores and had lower knowledge scores for clinical genetics resources, 
testing strategy, and test interpretation. These results signify a need for clinical genetics education 
that is pertinent to advancements in clinical genetics. While the sample size and ultimately the 
response rate in this study was small, this study adds to the growing body of literature concerning 
the gaps in genetic literacy of healthcare providers. In order to address these gaps, a clinical 
genetics curriculum for medical students should build a solid foundation in basic genetic concepts 
and promote adaptability to keep pace with the ever-changing nature of the field through awareness 
of clinical genetics resources and practice guidelines.89 Dedicating more contact hours to clinical 
genetics would be beneficial, but in the context of medical student’s dense curriculum, this is not 
always feasible. Rather, it would be worthwhile to incorporate experiences that expose students to 
the integration of genetics into clinical practice. Suggestions for such experiences include more 
standardized patient roleplays, patient-led educational sessions, and genetics case presentations.81 
It is imperative that non-genetics healthcare providers possess a strong foundation in basic genetics 
clinical concepts, as well as maintain standing relationships with genetics specialists, in order to 
provide the best care for patients with a suspected or an established genetic condition.  
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4.0 PUBLIC HEALTH AND GENETIC COUNSELING SIGNIFICANCE 
This study addresses the genetics knowledge of medical students, which forms the basis of 
their ability to communicate effectively to inform and educate future patients about genetics as it 
relates to their personal health and their health of the family members. In considering the three 
core functions of public health, this study focuses on assurance, namely by identifying barriers to 
building and supporting a skilled public health workforce and assuring an effective healthcare 
system that enables equitable access for all patients. To build a skilled public health workforce, 
medical students must possess basic knowledge of clinical genetics concepts and resources to make 
appropriate decisions regarding genetic information in the clinical setting as future physicians. The 
current iteration of the Association of Professors of Human and Medical Genetics (APHMG) core 
curriculum, used by most medical school human genetics course directors, emphasizes that 
students have sufficient knowledge of basic genetic principles including inheritance, genome 
organization, and genetic variation, as well as the ability to apply those skills by demonstrating the 
ability to gather family history information, construct and interpret a family pedigree, assess risk 
for a genetic disorder, and determine when a complete genetics evaluation is appropriate.79 This 
study determined that medical students’ basic clinical genetics knowledge is incomplete, with a 
possible overconfidence in that knowledge, which suggests that the amount of time devoted to 
genetics education in medical school may be insufficient. Studies have shown that physicians with 
limited formal genetics education are at increased risk of accidentally ordering the wrong genetic 
test, failing to refer a patient in need of genetic services, or unintentionally providing 
misinformation during results disclosure.3-6 These scenarios jeopardize the quality of care for 
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patients, particularly those with limited health and genetic literacy, which does not equate to 
equitable access to healthcare for all members of the general population.13 
Genetic counselors can play a pivotal role in genetics education for medical students and 
physicians. Genetic counselors receive specialized training to communicate complex genetic 
information to individuals of all backgrounds, from patients with low genetic literacy to highly 
trained physicians, and they are utilizing their skills in new roles, one of which is the education of 
physicians and other non-genetics healthcare providers. Many healthcare systems have already 
instituted utilization management programs to implement review of genetic test orders by a genetic 
counselor prior to request for insurance authorization. These programs mitigate unnecessary 
genetic testing expenditures, foster relationships between physicians and genetic specialists, and 
serve as a feedback loop for physicians in selecting the appropriate genetic tests.38 However, 
physicians should also be receiving more comprehensive genetics education during the course of 
their training, which can be supplemented by continuing education coursework and clinical 
experience in the clinic. Featuring genetics specialists more prominently in medical school Human 
Genetics courses, or even having genetics clinicians teach genetics courses, could promote the 
field and lead to a greater recognition of the ways in which genomics is being integrated into 
clinical practice. Genetic counselors are well suited to lead continuing education opportunities to 
help practicing healthcare providers develop their genetics knowledge. As the profession continues 
to expand, genetic counselors should be encouraged to take on roles in the education of non-
genetics healthcare professionals to shift the perception of genetics as a field of rare disease, to 




Appendix A Supplemental Figures 




Participant ID Confidence Rating Total Confidence Score
A 4 5 5 4 5 4 5 4 4 5 5 5 55
B 5 5 5 2 4 4 5 5 4 5 4 5 53
C 5 5 4 4 2 2 4 1 3 4 2 2 38
D 1 1 1 2 1 2 1 3 1 1 1 1 16
E 5 5 5 4 4 5 4 3 5 4 4 5 53
F 5 5 5 4 4 4 4 3 4 4 3 4 49
G 5 4 4 4 4 3 3 2 4 4 3 5 45
H 5 5 5 4 2 3 5 1 3 3 4 4 44
I 5 5 4 4 5 3 4 4 4 5 5 4 52
J 5 5 4 5 4 5 5 4 4 5 4 4 54
K 5 5 5 4 5 5 5 2 4 5 5 5 55
L 5 5 5 4 4 3 3 4 3 5 4 5 50
M 5 5 5 4 4 4 5 5 4 4 4 4 53
N 5 5 5 4 2 4 5 2 4 4 3 4 47
O 5 5 4 4 5 4 5 4 4 5 5 5 55
Mean Score 4.667 4.667 4.4 3.8 3.667 3.667 4.2 3.133 3.667 4.2 3.733 4.133 47.93
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Appendix C Research on Medical Students (ROMS) Committee Approval 
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Appendix D Recruitment Email 




My name is Ravella Raker and I am currently a graduate student in the University of 
Pittsburgh Genetic Counseling Program. 
 
As a University of Pittsburgh medical student who took Human Genetics during the Fall 
2020 semester, you are eligible to complete a survey that is designed to assess knowledge of 
clinical genetics and genetic testing. Ultimately, we hope this survey will inform efforts to improve 
and integrate graduate level genetics curriculum for future physicians. Please consider taking this 
anonymous survey, which will deepen our understanding of the current gaps and limitations of 
genetics education in medical school.  
 
The survey should take about 20-30 minutes to complete. There are minimal risks 
associated with participation in this survey, including but not limited to the infrequent risk of a 
breach of confidentiality. There are no direct benefits to you in return for your participation. You 
will not receive any form of compensation as part of this study. Participating in this survey will 
not positively or negatively impact your academic standing within the University of Pittsburgh 
School of Medicine. 
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This is an anonymous questionnaire, and your responses will not be identifiable. All 
responses are confidential, and results will be secured electronically. Your participation is 
voluntary. You may skip questions or stop the survey at any time by exiting the survey, though all 
responses submitted up until the point of exit will be maintained.  If you choose to withdraw from 
this study, all data collected prior to the date of withdrawal will continue to be used. 
 
This study has been approved by the University of Pittsburgh IRB. 
 
Should you have any questions, please feel free to email me at:  RAR175@pitt.edu. Thank 
you for considering taking this survey and I appreciate your assistance in providing information 
that has potential to enhance genetics education in medical school. 
 
The following link: https://pitt.co1.qualtrics.com/jfe/form/SV_7VYHFYBds92BcTr  will 




Appendix E Survey 
Genetic Literacy in Medical Students 
 
 
Start of Block: Self-Assessment of Clinical Genetics Knowledge and Skills 
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Q1 Please rate your knowledge relating to each genetics-based competency on a 5-point 













I understand the 
foundational concepts 
of genome 
organization. (1)  
 
o o o o o 
I understand the 
foundational concepts 
of genetic inheritance. 
(2)  
 
o o o o o 
I understand how the 
fundamentals of 
population genetics 




o o o o o 
I can gather a detailed 
family history for a 
genetic indication. (4)  
 
o o o o o 
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I can assess genetic 
risk based on the 
information within a 
family history. (5)  
 
o o o o o 
I am comfortable 
identifying indications 
for referral to a 
genetics specialist. (6)  
 
o o o o o 
I can apply knowledge 
of genetic principles 
to effectively 
communicate with 
patients who have 
limited genetic 
literacy. (7)  
 
o o o o o 
I am familiar with 
clinical genetics 
resources and 
databases. (8)  
 
o o o o o 
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I am knowledgeable 
about the principles of 
cytogenetics and 
molecular genetic 
techniques (9)  
 
o o o o o 
I can describe the 
benefits, risks, and 
limitations of genetic 
testing to a patient. 
(10)  
 
o o o o o 
I have thorough 
knowledge of genetics 
relating to the 
development, 
diagnosis, and 
treatment of cancer 
(11)  
 
o o o o o 
I am aware of 
methods for prenatal 
diagnosis of genetic 
conditions. (12)  
o o o o o 
 
 
End of Block: Self-Assessment of Clinical Genetics Knowledge and Skills 
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Start of Block: Inheritance 
 
Q2 What is the chance that a healthy child whose sibling has an autosomal recessive genetic 
condition will be a carrier? 
o25%  (1)  
o50%  (2)  
o66%  (3)  





Q3 A woman marries her 1st cousin, once-removed. Which scenario is most likely? 
oTheir child is at increased risk to develop an autosomal dominant condition  (1)  
oTheir child is at increased risk to develop an autosomal recessive condition  (2)  
oTheir child is at increased risk to develop an X-linked dominant condition  (3)  






Q4 A healthy man whose brother has an autosomal recessive genetic condition marries a 
woman with no family history of this condition. The carrier frequency in the general population 
for this condition is 1/25, i.e., 1 in 25 individuals in the general population carries one pathogenic 
variant for this autosomal recessive condition. What is the probability that their child would be 
affected by this condition? 
o1/150  (1)  
o1/400  (2)  
o1/75  (3)  






Q5 Select the statement that best describes X-linked recessive inheritance: 
oThe children of affected males are not at risk for being affected with the condition  (1)  
oThe children of carrier females are not at risk for being affected with the condition  (2)  
oBoth males and females are affected equally  (3)  




Q6 True or False: For multifactorial conditions, when the phenotype is more common in 
one sex, the risk is higher for relatives of the proband of the less susceptible sex. 
oTrue  (1)  





Q7 What is the chance for a male with deletion of the 22q11.2 region, otherwise known as 
DiGeorge syndrome, to have a child with this same condition? 
oLess than 1%  (1)  
o25%  (2)  
o33%  (3)  




Q8 A pregnant woman comes for genetic counseling because the father of her female fetus 
has Leber's hereditary optic neuropathy (LHON), a mitochondrially inherited genetic condition. 
What is the chance that this fetus is affected with LHON? 
o0%  (1)  
o25%  (2)  
o33%  (3)  
o50%  (4)  
 
End of Block: Inheritance 
 
Start of Block: Clinical Genetics Scenarios 
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Q9 A female patient with breast cancer reports that she has undergone genetic testing and 
was found to have the "gene for breast cancer". Which of the following is safe to assume based 
solely on the patient's statement? 
oThat she has received appropriate genetic counseling through a genetic counselor or 
physician.  (1)  
oThat she has a pathogenic variant in a gene associated with an increased risk for breast 
cancer.  (2)  
oThat the genetic testing ordered for this patient was sufficient to cover all known causes 
of hereditary breast cancer.  (3)  





Q10 A 21 year old woman reports that her mother had a BRCA1 mutation and provides 
you with the report confirming this information. She is unwilling to undergo genetic testing at this 
stage in her life, but is fearful of developing cancer. How do you counsel this patient? 
oRefer her to a high-risk breast cancer screening and management program.  (1)  
oAddress the psychosocial concerns of the patient.  (2)  
oDiscuss lifestyle modification, medication, and surgical recommendations  (3)  




Q11 A 30-year-old woman with comes to the genetics clinic for BRCA1 and BRCA2 
testing. She does not have breast cancer, but her mother was diagnosed with breast cancer at age 
45, her first cousin was diagnosed with breast cancer at age 35, and her paternal aunt was diagnosed 
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with breast cancer at age 65. To clarify the woman's risk, which of the following individuals should 
be tested first? 
oThe woman  (1)  
oHer mother  (2)  
oHer first cousin  (3)  





Q12 A woman with hereditary nonpolyposis colorectal cancer, otherwise known as Lynch 
syndrome, wants her 14 year old daughter to be tested for the known familial mutation. What do 
you tell this woman and her daughter? 
oReassure the mother that her daughter is not likely to develop cancer in the next ten years, 
therefore genetic testing is unnecessary.  (1)  
oGenetic testing for her daughter is not warranted unless her daughter develops cancer 
before age 30.  (2)  
oGenetic testing for her daughter is appropriate at this time, as childhood cancers are 
common in Lynch syndrome.  (3)  
oGenetic testing for Lynch syndrome is typically not recommended for children younger 





Q13 A 5 year old girl presents to your clinic with dysmorphic features, developmental 
delay, microcephaly, prominent jaw, and a history of seizures. What is the most appropriate genetic 
test to order for this child? 
oWhole exome sequencing  (1)  
oMicroarray  (2)  
oFISH testing for 22q  (3)  




Q14 When is it LEAST appropriate to order a karyotype? 
oIf you are concerned about a translocation due to a parental history of multiple 
miscarriages.  (1)  
oIf you suspect the patient has Down syndrome.  (2)  
oIf your patient has multiple congenital anomalies.  (3)  





Q15 A woman is referred to your clinic at 19 weeks gestation because her amniocentesis, 
performed for advanced maternal age, revealed a karyotype of 47XXY (Klinefelter syndrome). 
The woman and her partner are tearful, and are debating whether to terminate the pregnancy. How 
would you discuss this result with the couple? 
oTell the couple that it would be in their best interest to continue the pregnancy.  (1)  
oProvide a wealth of detailed information about the features of Klinefelter syndrome.  (2)  
oRemind the couple that Klinefelter syndrome is not associated with a decrease in life 
expectancy.  (3)  






Non-Invasive Prenatal Testing (NIPT) has a very high detection rate for Down syndrome, 
therefore, diagnostic testing is not needed following a positive NIPT. Is this statement true or false? 
oTrue  (1)  
oFalse  (2)  
 
End of Block: Clinical Genetics Scenarios 
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Start of Block: Interpretation of Genetic Test Results 
 
Q17 A couple whose child had a positive newborn screen for cystic fibrosis presents to 
your clinic for counseling. The child's sweat test returns negative and genetic testing reveals one 
mutation: a F508 deletion. What do these results mean for the child? 
oThe child has cystic fibrosis.  (1)  
oThe child has CFTR-Related Metabolic Syndrome (CRMS).  (2)  
oThe child is a carrier for cystic fibrosis  (3)  




Q18 An infant with deletion of the 22q11.2 region, otherwise known as DiGeorge 
syndrome, is evaluated by medical genetics. Neither of the child's parents carry the deletion. The 
parents are interested in having more children and want to know their risk of having another 
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affected child. What information would you provide when discussing recurrence risk for future 
pregnancies? 
oThe parents are at slightly increased risk to have a child with DiGeorge syndrome due to 
the possibility of germline mosaicism  (1)  
oIf they have another child with DiGeorge syndrome, that child would have the same 
features of DiGeorge syndrome as their first child.  (2)  
oThe parents are not at increased risk to have another child with DiGeorge syndrome.  (3)  




Q19 A genetic test report reveals a "variant of unknown significance". What does this result 
mean for the patient? 
oChanges in medical management are warranted depending on the exact variant.  (1)  
oOrdering providers are not required to inform patients of such a result.  (2)  
oMedical management decisions should not be made based on a variant of unknown 





Q20 Which of the following methods can be used to determine the clinical meaning of a 
variant of uncertain significance? 
oRepeat the test.  (1)  
oTest other affected family members to see if the variant tracks with the phenotype of 
interest in the family.  (2)  
oTest another tissue type (instead of blood use skin fibroblasts or buccal swab).  (3)  





If a fetus has an increased nuchal translucency, which of the following karyotype results is the 
most likely to be found on amniocentesis? 
o45, X  (1)  
o45, X/46, XX  (2)  
o46, XX  (3)  
o47, XX, +21  (4)  
 
End of Block: Interpretation of Genetic Test Results 
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Start of Block: Demographics 
 





Q23 How challenging was this course? 
oExtremely challenging  (1)  
oVery challenging  (2)  
oModerately challenging  (3)  
oSlightly challenging  (4)  





Q24 How much did you learn from this course? 
oA great deal  (1)  
oA lot  (2)  
oA moderate amount  (3)  
oA little  (4)  



















Q27 Did you take a genetics course during your undergraduate education? 
oYes  (1)  
oNo  (2)  




Q28 Do you have any prior work experience with genetics (laboratory positions, research, 
clinical observation)? 
oYes  (1)  
oNo  (2)  
oNot sure  (3)  
 
 
Display This Question: 
If Do you have any prior work experience with genetics (laboratory positions, research, clinical obs... = Yes 
Or Do you have any prior work experience with genetics (laboratory positions, research, clinical obs... = Not 
sure 
 






Q30 What is your gender? 
oMale  (1)  
oFemale  (2)  
oNon-binary  (3)  
oTransgender  (4)  
oOther:  (5) ________________________________________________ 
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